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Abstract 
Elg1, the major component of an alternative PCNA loader, is vital in maintaining 
chromosomal stability. PCNA is an essential coordinator for DNA replication and the 
damage response through protein-protein interactions. The N-terminus of Elg1 interacts 
with PCNA and preferentially SUMOylated PCNA (sPCNA) and contains five putative 
motifs for PCNA and SUMO binding. How these motifs contribute to PCNA interactions 
is unclear. In this study, we biochemically characterized the interactions between Elg1 and 
PCNA and found that i) two PCNA-interacting protein boxes (PIP boxes) participate in the 
interaction with PCNA, which may be interfered by the SUMO-interacting motifs (SIMs); 
ii) the Elg1 N-terminus binds to sPCNA with micromolar affinity, and mutations on SIMs 
have subtle effects on the binding affinity; iii) all three SIMs interact with SUMO. Given 
these findings, we propose that Elg1’s interaction with PCNA is promoted by SIMs upon 
SUMOylation and inhibited by SIMs when lacks PCNA SUMOylation. 
 
 
 
 
 
 
 
 
 
Keywords: Elg1, PCNA, PIP box, SUMO, SIM, Protein-protein interactions.
iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dedicated to my family, friends, and lab mates for their tireless support and 
encouragement.
iv 
 
Acknowledgements 
First and foremost, I would like to thank Dr. Hong Ling for allowing me an opportunity to 
pursue the Master’s degree in Biochemistry. The experience has been exceptional and 
rewarding. Dr. Hong Ling’s dedication in guiding me through the research and her support 
for the writing of the thesis was admirable in every sense of the word. Besides Dr. Hong 
Ling, I would also like to send my sincere gratitude to my advisory committee: Dr. Gary 
Shaw, for providing help on NMR experiments and perspectives on the project, and Dr. 
Chris Brandl, for his insightful advice and perspectives. It was a great enjoyment to work 
with them. Without these professors’ encouragement and support, it would not have been 
possible to conduct this research. 
Secondly, I would like to thank Dr. Guangxin Xing for generating most of the plasmids 
used in this study and to him and Dr. Vikash Jha in our lab for their aid in troubleshooting 
and advice. They have helped me overcome many obstacles, and it has been a pleasure to 
learn from them. To the members of the Lab, Dr. Chuanbing Bian, Lizhen Guo, Andy Liu, 
Rebecca Earnshaw, Sam Chu, Derek Tse, Harrison Taylor, Rashiq Shahad, and all the other 
undergraduate students. It was a great time to be working with you all and thank you for 
making my time here a unique one. My special thanks to Tam Bui, who trained me when I 
first started and has taught me so much. I would also like to thank Dr. Lynn Weir for her 
help on the thesis writing and Lee-Ann Briere for her training and kind advice. 
Finally, to my parents, I am thankful to have your love and support. To my friends and 
loved ones, thank you for being there whenever I needed you and for always putting a smile 
on my face.   
 
 
v 
 
Table of Contents 
Abstract ............................................................................................................................... ii 
Dedication ..........................................................................................................................iii 
Acknowledgements ........................................................................................................... iv 
Table of Contents ............................................................................................................... v 
List of Tables ..................................................................................................................... vii 
List of Figures ..................................................................................................................viii 
List of Appendices ............................................................................................................. ix 
List of Abbreviations and Acronyms ................................................................................ x 
1 Introduction ..................................................................................................................... 1 
1.1 Elg1 ............................................................................................................................ 2 
1.1.1 Clamp loader and Elg1-RLC ............................................................................... 2 
1.1.2 Elg1 protein .......................................................................................................... 2 
1.1.3 SIM and SUMO ................................................................................................... 3 
1.2 PCNA ......................................................................................................................... 5 
1.2.1 Yeast PCNA ......................................................................................................... 5 
1.2.2 PCNA-interacting protein motif (PIP Box) ......................................................... 6 
1.2.3 PCNA SUMOylation ........................................................................................... 9 
1.3 Research on Elg1-PCNA interaction ........................................................................ 11 
1.4 Rationale, hypothesis, and objectives ....................................................................... 11 
2 Materials and Methods ................................................................................................. 13 
2.1 Bacterial strains and plasmids .................................................................................. 13 
2.2 List of buffers ........................................................................................................... 16 
2.3 Cloning of constructs for expression ........................................................................ 17 
2.4 Expression and purification ...................................................................................... 18 
2.4.1 Expression and purification of yeast PCNA ...................................................... 18 
2.4.2 Expression and purification of SUMOylation enzymes and SUMO ................. 19 
2.4.3 Expression and purification of GST-fused Elg1 fragments ............................... 20 
2.4.4 Expression and purification of Elg1 WT and Elg1 SIM mutants ...................... 21 
2.5 SUMOylation of PCNA ........................................................................................... 21 
2.6 GST pull-down assay ............................................................................................... 22 
2.7 Isothermal titration calorimetry ................................................................................ 23 
2.8 NMR spectroscopy ................................................................................................... 24 
vi 
 
2.9 Crystallization .......................................................................................................... 25 
3 Results ............................................................................................................................ 26 
3.1 Interactions between Elg1 and PCNA/sPCNA ........................................................ 26 
3.1.1 Construct design of Elg1 SIM mutants .............................................................. 26 
3.1.2 Protein expression and purification ................................................................... 26 
3.1.3 SUMOylation of PCNA ..................................................................................... 34 
3.1.4 GST pull-down assay ......................................................................................... 34 
3.1.5 ITC ..................................................................................................................... 36 
3.1.6 Crystallization .................................................................................................... 45 
3.2 Interactions between Elg1 and Smt3 ........................................................................ 46 
3.2.1 Cloning, expression, and purification of His-Smt3 ........................................... 46 
3.2.2 GST pull-down assay ......................................................................................... 48 
3.2.3 ITC ..................................................................................................................... 48 
3.2.4 NMR .................................................................................................................. 53 
4 Discussion....................................................................................................................... 61 
4.1 Elg1’s interaction with PCNA .................................................................................. 61 
4.1.1 Two PIP boxes participate in the interaction with PCNA .................................. 61 
4.1.2 SIM1 and/or SIM2 may inhibit the interaction with PCNA .............................. 62 
4.2 Elg1’s interaction with sPCNA ................................................................................ 63 
4.2.1 Elg1 N-terminus is confirmed to bind sPCNA with µM affinity ....................... 63 
4.2.2 SIMs mutations have subtle effects on the interaction with sPCNA ................. 63 
4.3 Elg1’s interactions with Smt3 .................................................................................. 64 
4.3.1 Elg1 N-terminus is confirmed to bind Smt3 weakly ......................................... 64 
4.3.2 All three SIMs contribute to the interaction with Smt3 ..................................... 65 
4.3.3 Elg1’s interaction with Smt3 is likely to resemble Srs2 interactions ................ 66 
4.4 Proposed model for interactions with PCNA/sPCNA .............................................. 66 
4.5 Future directions ....................................................................................................... 67 
5 References ...................................................................................................................... 69 
6 Appendices ..................................................................................................................... 76 
Curriculum Vitae ............................................................................................................. 78 
vii 
 
List of Tables 
Table 1: List of proteins used in this study ........................................................................ 14 
Table 2: List of buffers used in this study .......................................................................... 16 
Table 3: A summary of GST pull-down assay results ........................................................ 40 
Table 4: A summary for ITC titrations between sPCNA and Elg1 .................................... 44 
Table 5: Summary of the ITC titrations between His-Smt3 and Elg1 ............................... 52 
Table 6: Summary of chemical shifts for apparent Kd in NMR ......................................... 58 
 
 
 
 
viii 
 
List of Figures 
Figure 1: Schematic diagram of Elg1 functional motifs ...................................................... 4 
Figure 2: Crystal structure of yeast PCNA .......................................................................... 7 
Figure 3: The sequence alignment of the PIP boxes in yeast proteins ................................. 8 
Figure 4: An overview of PCNA modifications and the pathways they direct .................. 10 
Figure 5: Previous results from our lab regarding Elg1-PCNA interaction ....................... 12 
Figure 6: Construct design of Elg1 SIM mutants .............................................................. 27 
Figure 7: Purification of yeast PCNA ................................................................................ 28 
Figure 8: SDS-PAGE analysis of SUMOylation enzymes and substrates ......................... 30 
Figure 9: Representative purification of GST-tagged Elg1 fragments .............................. 32 
Figure 10: Representative purification of Elg1 SIM mutants ............................................ 33 
Figure 11: Purification of SUMOylated PCNA ................................................................. 35 
Figure 12: Structure of Elg1 fragments and GST pull-down controls ............................... 37 
Figure 13: GST pull-down assays with various Elg1 N-terminal fragments ..................... 38 
Figure 14: GST pull-down assay with Elg1L3+ ................................................................ 39 
Figure 15: ITC titrations between sPCNA and Elg1/Elg1 SIM mutants ........................... 42 
Continued Figure 15: ITC titrations between sPCNA and Elg1/ Elg1 SIM mutants ........ 43 
Figure 16: Crystal hits observed from kits ......................................................................... 47 
Figure 17: Purification of His-Smt3 .................................................................................. 49 
Figure 18: GST pull-down assay with Elg1 N-terminal fragments and Smt3 ................... 50 
Figure 19: ITC titration between His-Smt3 and Elg1, or Elg1 SIM single mutants .......... 51 
Figure 20: 2D 1H-15N spectrum of Smt3 Δ18K19R with assignments .............................. 55 
Figure 21: 2D 1H-15N spectrum of Smt3 Δ18K19R, free and in complex with various 
concentrations of Elg1 WT ................................................................................................ 56 
Figure 22: The fitting curves of chemical shifts used to calculate binding affinity ........... 57 
Figure 23: Chemical-shift perturbations of assigned residues in Smt3 Δ18K19R ............ 59 
Figure 24: Elg1 binding surface mapped on the Smt3 ....................................................... 60 
Figure 25: Proposed model of the interactions between Elg1 and PCNA/sPCNA ............ 68 
 
 
ix 
 
List of Appendices 
Appendix A: Table of primers that were used to generate new constructs ........................ 76 
Appendix B: SUMOylation tested at different time points ............................................... 76 
Appendix C: ITC titration of Elg1 and PCNA................................................................... 77 
 
 
x 
 
List of Abbreviations and Acronyms 
Amino Acids  
 Ala (A) alanine 
 Arg (R) arginine 
 Asn (N) asparagine 
 Asp (D) aspartic acid 
 Cys (C) cysteine 
 Gln (Q) glutamine 
 Glu (E) glutamate 
 Gly (G) glycine 
 His (H) histidine 
 Ile (I) isoleucine 
 Leu (L) leucine 
 Lys (K) lysine 
 Met (M) methionine 
 Phe (F) phenylalanine 
 Pro (P) proline 
 Ser (S) serine 
 Thr (T) threonine 
 Trp (W) tryptophan 
 Tyr (Y) tyrosine 
 Val (V) valine 
   
°C degrees Celsius 
µl microliter 
µM micromolar 
Å angstrom 
AAA+ ATPases associated with diverse cellular activities 
ATAD5 ATPase family, AAA domain-containing protein 5 
ATP adenosine triphosphate 
CaCl2 calcium chloride 
D2O deuterium oxide, water composed of deuterium 
DNA deoxyribonucleic acid 
DSS 4,4-dimethyl-4-silapentane-1-sulfonic acid 
EDTA ethylenediaminetetraacetic acid 
Elg1 enhanced level of genome instability 
FT flow through 
GST glutathione S-transferase 
hPCNA human PCNA 
IDCL interdomain connecting loop 
IPTG isopropyl β-D-1-thiogalactopyranoside 
ITC isothermal titration calorimetry 
 
 
xi 
 
Kd dissociation constant 
kDa kilodalton 
LB lysogeny broth 
M molar 
MBP maltose-binding protein 
MgCl2 magnesium chloride 
mM millimolar 
MMS methyl methanesulfonate 
Mocr modified ocr tag 
NaCl sodium chloride 
NH4Cl ammonium chloride 
NLS nuclear localization signal 
nM nanomolar 
NMR nuclear magnetic resonance 
NP-40 nonyl phenoxypolyethoxylethanol 
PCNA proliferating c6fell nuclear antigen 
PCR polymerase chain reaction 
PEG  polyethylene glycol 
pH potential of hydrogen 
PIP box PCNA-interacting motif 
PIPE polymerase incomplete primer extension 
PMSF phenylmethylsulfonyl fluoride 
Pol η polymerase η 
RFC replication factor C 
RLC replication factor C-like complex 
rpm revolutions per minute 
S. cerevisiae  Saccharomyces cerevisiae 
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SIM SUMO-interacting motif 
Smt3 suppressor of mif two 3 
sPCNA SUMOylated PCNA 
SUMO small ubiquitin-like modifier 
TCEP tris (2-carboxyethyl) phosphine 
β-me β-mercaptoethanol  
  
  
  
  
  
  
  
  
1 
 
 
1 Introduction 
Cells are constantly subjected to intracellular and/or extracellular DNA damage factors. In 
the cell, DNA replication and repair are regulated by a complex network that involves 
multitudes of protein-protein interactions. Enhanced level of genome integrity protein 
(Elg1) was first found as a contributor to chromosomal stability in yeast [1]. Elg1 has been 
shown to form a replication factor complex (RFC)-like complex (Elg1-RLC) and functions 
in DNA replication. Elg1 mutants display defects not only in DNA replication but also in S 
phase progression with the presence of methyl methanesulfonate (MMS), suggesting that 
Elg1 has a role in DNA damage response [1-2]. Studies have shown that Elg1-RLC 
mediates the process of proliferating cell nuclear antigen (PCNA) loading/unloading via 
direct protein-protein interactions [3-5].  
PCNA lies at the center of DNA replication and orchestrates DNA repair pathways to 
handle various errors made in the genome via interactions with PCNA’s numerous partner 
proteins [6-8]. As the processivity factor for polymerases, PCNA needs to be loaded onto 
the DNA during DNA synthesis [9-11]. On the other hand, PCNA must also be timely 
unloaded from DNA after DNA synthesis, which is mediated by Elg1-RLC in yeast [12-
13]. Because of its roles in fundamental cellular functions, including genome replication, 
repair, and maintenance, PCNA is recognized as a potential anticancer target. Compounds 
targeting PCNA have been found to inhibit tumor cell growth [14-15]. 
Defects in PCNA unloading activity mediated by Elg1 result in various types of 
chromosome instability, such as DNA damage sensitivity, replication defects, and enhanced 
homologous recombination [5, 16]. Although Elg1 has been shown to have a role in 
unloading the DNA-bound PCNA from the template, the mechanism of how Elg1 mediates 
this process remains unclear. Investigations on interactions between Elg1 and PCNA will 
shed some light on the mechanism of PCNA unloading and its role in the DNA damage 
response, which would further extend the understanding of the complex network around 
PCNA and help future PCNA-targeted drug design. 
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1.1 Elg1 
1.1.1 Clamp loader and Elg1-RLC 
In order to achieve high-speed replication, DNA polymerases must attach to a sliding clamp 
(PCNA is the major one in eukaryotes) [17]. A clamp loader loads the sliding clamp onto 
DNA and timely unloads it from DNA during replication. Clamp loaders all belong to the 
AAA+ (ATPases associated with various cellular activities) family of ATPases [18] and 
interact with the sliding clamp during DNA replication and damage responses. Several 
protein complexes are responsible for loading/unloading the sliding clamp. RFC is the 
major loader for the loading and unloading of PCNA in yeast [19].  
In addition to RFC, other non-canonical replication factor C-like complexes (RLCs) exist 
that are conserved in eukaryotes, such as Ctf18-RLC and Rad24-RLC [20-22]. Elg1 is also 
found to form an alternative RLC in yeast and is composed of five subunits - four small 
subunits (Rfc 2, 3, 4, and 5) and one large subunit Elg1, instead of Rfc1 in RFC. All these 
subunits contain a Walker motif that can hydrolyze ATP to drive the loading/unloading 
process [1].  
1.1.2 Elg1 protein 
Elg1 was first identified as a contributor to chromosomal stability in S. cerevisiae [5]. Elg1 
shares limited sequence homology with its human ortholog ATPase family, AAA domain-
containing protein 5 (ATAD5). Elg1 contains several conserved cores of AAA+ family 
(Figure 1A), and Elg1 can form RLCs that interact with PCNA, similar to Rfc1 [1, 23]. 
Although the N-terminus of Elg1 is predicted to be disordered, several functional motifs 
are found in the N-terminus, including a nuclear localization signal (NLS), three SUMO-
interacting motifs (SIMs) (small ubiquitin-related modifier, SUMO), and a proposed 
PCNA-interacting motif (PIP box) (Figure 1B) [2, 24]. Elg1’s central domain contains a 
non-canonical Walker motif that does not utilize ATP effectively, suggesting that the 
unloading activity is performed through the energy provided by the other four subunits [24]. 
Elg1’s C-terminus is established to be significant in the formation of the RLC complex. 
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Yeast strains that lack amino acids 521–731 of Elg1 are not able to form RLC. Elg1-RLC 
assembly is likely to resemble the canonical RFC complex formation, where deletion of the 
C-terminus of any of the subunits (Rfc2, 3, 4, or 5, Elg1) abrogates complex formation 
[24]. 
Elg1 has been shown to bind PCNA and, preferentially, SUMOylated PCNA. A sequence 
of a PIP box has been identified in Elg1, and all three SIMs are able to bind to Smt3 (SUMO 
in yeast) alone in vivo [2]. However, little is known about how those SIMs promote Elg1’s 
interaction with SUMOylated PCNA (sPCNA). Nonetheless, the interaction between Elg1 
and PCNA/sPCNA is critical for normal cell growth. The nature of the interaction still 
needs to be further characterized for a better understanding of the role of Elg1. 
1.1.3 SIM and SUMO 
Elg1 contains three SIMs in its N-terminus, and their roles in the interaction with sPCNA 
are not well understood. SIM is a short stretch of residues that interacts with a specific 
surface groove of SUMO. Most of the SIMs that have been identified contain two important 
elements: a core of 3-4 hydrophobic residues (usually V or I) and a nearby acidic region, 
which contains a stretch of E or D or phosphorylated S or T [25]. In the case of Srs2, the 
yeast DNA helicase, the PIP box and SIM in its C-terminus can bind to PCNA and SUMO 
independently. The presence of both SIM and the PIP box in Srs2 enhances its interaction 
with sPCNA at least 7-fold compared to that with PCNA alone [26].  
SUMO proteins are the ubiquitin-like modifiers that conjugate with certain substrates and 
regulate cellular processes, such as gene expression, DNA repair, chromosome assembly, 
and cellular signaling [27]. While yeast has only one SUMO, four SUMO isoforms have 
been identified in humans [28]. Even though the functions of SUMO can be distinctive, 
their main role is to regulate the interactions of the modified protein with other proteins. 
Most proteins that contain SIM would non-covalently bind to SUMO or the SUMO that is 
conjugated to the substrate.  
It has been revealed that Elg1-RLC preferentially unloads sPCNA, as Elg1-RLC preferenti- 
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Figure 1: Schematic diagram of Elg1 functional motifs. 
A) The conserved sequence in S.cerevisiae is shown in blocks. All square blocks that 
marked with roman numerals in the central domain represent the conserved cores for the 
AAA+ family. (Adapted from Bellaoui et al. [1]). These square blocks in the Elg1 N-
terminus represent the functional motifs that have been identified;  
B) The amino acid sequence of Elg1 1-150 is shown, along with a bar diagram that shows 
the functional motifs involved in the interactions. The NLS, PIP boxes (described later in 
preliminary research), and SIMs are marked in grey, yellow, and light blue, respectively. 
The red square outlines the proposed PIP box in Parnas et al. [2]. 
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-ally interacts with sPCNA, and yeast strains that lack Elg1 show a significant accumulation 
of sPCNA on chromatin [2]. However, the mechanism of how the SIMs in Elg1’s N-
terminus work coordinately with the PIP box remains unclear. Elg1 may interact with 
SUMOylated PCNA in a similar manner like Srs2 to enhance binding affinity to PCNA, 
where the interaction with PCNA and the interaction with SUMO are independent of each 
other. 
1.2 PCNA 
PCNA is a homo-trimeric ring-shaped protein that coordinates with various proteins 
involved in DNA metabolism. It serves as a platform that facilitates the recruitment of 
proteins involved in DNA replication and DNA damage response pathways. During 
replication, PCNA interacts with DNA polymerase ε to facilitate leading-strand replication, 
while it works with DNA polymerase δ to synthesize DNA discontinuously in a series of 
Okazaki fragments on the lagging strand [29]. PCNA needs to be loaded repeatedly onto 
the DNA when each Okazaki fragment is synthesized [30]. Failure to unload PCNA can 
cause abnormalities in DNA replication and chromosome malformation.  
PCNA also functions in many other processes, such as translesion synthesis, error-free 
damage bypass, homologous recombination, mismatch repair, and chromatin assembly [31-
35]. Upon DNA damage, the major metabolic pathways to repair DNA include nucleotide 
excision repair, base excision repair, double-strand break repair, and mismatch repair, in 
which PCNA participates with its partners to coordinate the processes [36]. The diversified 
functions of PCNA are regulated by its interactions with different types of proteins. 
1.2.1 Yeast PCNA 
Recognized as the major sliding clamp, PCNA in yeast is encoded by the POL30 gene, 
which codes for a protein of molecular weight of approximately 29 kDa. Yeast PCNA 
shows 35% homology in sequence with human PCNA [37]. Despite the poor similarity in 
the primary sequences of PCNAs among bacteria, archaea, and eukaryotes, the overall 
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structure of PCNAs is highly conserved. The first crystal structure of yeast PCNA was 
determined in 1994 [38]. The structure showed that PCNA exists as a homotrimer and that 
each monomer is composed of three repeated domains (Figure 2). The two domains, the N-
terminus and the C-terminus, of each monomer are topologically identical and are 
connected to each other via the interdomain connecting loop (IDCL) (Figure 2).  The three 
monomers of PCNA are arranged in a head-to-tail orientation, which gives them a closed 
ring-shaped structure. 
 
The diameter of the center cavity of yeast PCNA is approximately 35 Å (Figure 2), which 
is sufficiently large to allow the double helix of DNA to pass through. The PCNA inner 
surface comprises 12 α-helices that are positively charged due to lysine and arginine 
residues, which allow the smooth passage of negatively charged DNA through the ring 
[39]. The PCNA outer surface comprises a set of β sheets, which stabilizes the interactions 
among the monomeric PCNAs. The head-to-tail arrangement of the PCNA monomers gives 
rise to two distinct faces, the front, and the back. The front face contains the IDCL, which 
bridges the amino-terminal domain and the carboxyl-terminal domain. The IDCL and the 
hydrophobic region on PCNA are responsible for making the contacts with binding 
partners. IDCL also contains sites for modification, which may alter its interaction with 
other partners and trigger a switching of functional pathways [40-41]. Several proteins have 
been shown to bind PCNA through interactions with IDCL, such as Fen1, Cdc9, and Srs2 
[26, 42-43]. The role of PCNA’s back face remains unclear. However, it has emerged as a 
site of PCNA post-translational modification [39]. 
1.2.2 PCNA-interacting protein motif (PIP Box) 
Proteins that PCNA recruits share a sequence-consensus motif called the PIP-box. The 
sequence alignment of several PCNA-binding proteins reveals that this motif comprises the 
Q-X-X-(L/M/I/V)-X-X-(F/Y)-(F/Y) sequence (Figure 3) [36], where X represents any 
amino acid. The PIP motif forms a 310 helix that acts as a hydrophobic anchor and facilitates 
binding to the surface of PCNA [43]. After the structure of the first PCNA in complex with 
a peptide (PCNA-p21) was determined [44], more PCNA-peptide complex structures were 
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Figure 2: Crystal structure of yeast PCNA. 
Figure constructed using 1PLQ structure from Protein Data Bank (PDB) shows the front 
view of PCNA. Each monomer is colored differently, and 3 monomers form the trimer in 
a head-to-tail manner. Also shown is that the center ring with a diameter of approximately 
35Å (measured via Pymol). The position of one monomer’s IDCL is indicated with an 
arrow at the front face of the PCNA trimer. The K164s (SUMOylation sites) are also 
indicated. 
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Figure 3: The sequence alignment of the PIP boxes in yeast proteins. 
The alignment of several yeast proteins that have been shown to interact with PCNA is 
presented in this figure, including canonical and non-canonical ones. The canonical amino 
acids are highlighted. 
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subsequently determined, including Cdc9, Srs2, and TRAIP [26, 43, 45]. Moreover, some 
proteins have been found to contain multiple PIP boxes. For instance, human Pol η contains 
three PIP boxes that contribute differently to two distinct functions. One is to stimulate 
DNA synthesis, and another is to promote PCNA mono-ubiquitination [46]. Additionally, 
human Pol η not only possesses three PIP boxes, but also contains a ubiquitin-binding motif 
that results in its preferential interaction with mono-ubiquitinated PCNA and functions to 
synthesize DNA in an error-prone manner [46]. Some proteins possess another PCNA 
binding motif, instead of the PIP box, called the KA box. The consensus sequence of the 
KA box is K-A-(A/L/I)-(A/L/Q)-X-X-(L/V), where X represents any amino acid [47]. 
However, no consensus sequences of the PIP box and KA box were found in Elg1. 
1.2.3 PCNA SUMOylation 
PCNA can be modified in a multitude of ways, such as mono- and poly-ubiquitination, 
SUMOylation, phosphorylation, and acetylation (Figure 4) [48-52]. The different 
modifications on PCNA regulate its functions by altering its interactions with numerous 
binding partners. For example, ubiquitination of PCNA directs error-prone and error-free 
replication when the cell undergoes replication stresses. The mono-ubiquitination of PCNA 
facilitates the recruitment of translesion synthesis polymerases at the stalled replication fork 
and allows the replication to continue [50], while poly-ubiquitination of PCNA is believed 
to play a role in error-free damage avoidance through template switching [53].  
In yeast, the SUMO modification of PCNA occurs mostly at K164 and to a small extent at 
K127 [48]. PCNA SUMOylation is not required for replication in undisrupted cells and is 
not a substitute in the absence of ubiquitination [54]. Although extensive research has been 
conducted to investigate the functions of PCNA SUMOylation, it is still not clearly 
understood. One major finding is that sPCNA can recruit Srs2 to the sites of replication 
where Srs2 can disrupt Rad51 filaments and prevent homologous recombination [55]. The 
C-terminus of Srs2 contains a non-canonical PIP box and a SIM which bind independently 
with PCNA and Smt3, respectively. Both motifs are required to recognize sPCNA [26]. In  
 
 
 
 
Figure 4: An overview of PCNA modifications and the pathways they direct. 
Upon DNA damage, PCNA would undergo different types of modification, which subsequently results in preferred interactions with corresponding 
proteins and leads to different pathways. The PCNA trimer is marked in blue. Ubiquitin, SUMO, phosphate, and acetyl are represented in light blue, 
yellow, green, and red, respectively.
1
0 
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addition, it has also been shown that Elg1-RLC, which is the alternative clamp loader, 
preferentially binds to sPCNA and assists in unloading sPCNA from DNA [1-2]. It was 
proposed to interact with sPCNA in a similar manner as Srs2. 
1.3 Research on Elg1-PCNA interaction 
Substantial investigations have been conducted on Elg1-PCNA interactions [1-2, 5, 16]. 
Several attempts have been made to understand the mechanism of PCNA unloading 
facilitated by Elg1. It has been proposed that the N-terminus of Elg1 mainly mediates the 
interaction with PCNA, and SIMs would promote the interaction between Elg1 and PCNA 
upon SUMOylation. Parnas et al. [2] have confirmed the ability of Elg1’s N-terminus to 
bind PCNA and proposed a PIP box from yeast-2-hybrid assays. 
On the other hand, pull-down assays in our lab with Elg1L3+ protein (33-84), which 
contains only the predicted PIP box, but no SIMs, have validated its binding ability with 
PCNA. It was also observed that, in the Elg1L3+ (33-84) construct, the mutations not only 
on (F53L54, V58, P61I62), but also outside of the proposed PIP box reduced binding to 
PCNA. This region contains two hydrophobic amino acids (F75L76) (Figure 5A), which 
are equally important for the interaction with PCNA. We, therefore, realigned the sequence 
of the Elg1 N-terminus using Clustal Omega (Figure 5B) and found that the consecutive 
hydrophobic amino acids on the proposed PIP box and outside of the PIP box are possibly 
conserved for interaction with PCNA. We proposed that these two potential PIP boxes 
would both contribute to the interaction with PCNA. The positions of these two PIP boxes 
are also marked in Figure 1B. 
1.4 Rationale, hypothesis, and objectives 
The Elg1-PCNA interaction mediates the unloading activity of PCNA, thereby regulating 
PCNA’s performance during DNA replication and repair. Elg1-RLC is well known as the 
major unloader of PCNA in yeast. Previous research has localized the “PIP box” of Elg1 
on its N-terminus [2, 5], and our lab’s preliminary investigations find two possible PIP 
boxes in the Elg1 N-terminus. Following our lab’s previous research, both proposed PIP  
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Figure 5: Previous results from our lab regarding Elg1-PCNA interaction. 
These results come from Andy Liu’s thesis. A) Representative GST pull-down assay on 
SDS-PAGE analysis. GST, GST-fused Elg1L3+ (33-84) and its mutants (contain point 
mutations) were used as bait, and PCNA (from yeast) was used as prey in GST pull-down 
assays. It shows the mutation on F53L54, V58, P61I62, F75L76 are important to the 
interaction with PCNA. The positions of yeast PCNA and GST are indicated on the right; 
B) Sequence alignments using Omega Cluster for the canonical amino acids with multiple 
yeast proteins that contain PIP boxes. The alignment results suggested that Elg1 may 
contain two potential PIP boxes.  
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boxes that interact with PCNA were further investigated in this study. Additionally, Elg1 
shows preferential binding with sPCNA, based on pull-down assays, and yeast 2-hybrid 
studies have determined that all three SIMs of Elg1 can interact with Smt3 [2]. However, 
the mechanism of how SIMs promote Elg1’s binding with sPCNA remains unclear, with 
the possibility that only one or two SIMs promote the interaction upon SUMOylation. 
To address these questions, we hypothesized that both proposed PIP boxes interact with 
PCNA and all three SIMs contribute to the interaction with sPCNA. Two biochemical 
approaches, GST pull-down assays and isothermal titration calorimetry (ITC), were utilized 
in this thesis to evaluate the role of two proposed PIP boxes and three SIMs in the 
interactions between Elg1 and PCNA/sPCNA. In addition, nuclear magnetic resonance 
(NMR) was employed to better understand the SIMs’ binding model with Smt3.  
This study has two main aims: 
 to identify the PIP box that plays the major role in the interactions with PCNA 
 to understand the roles of Elg1 SIM(s) in the interactions with sPCNA 
Better characterizations of Elg1-PCNA interaction would elucidate the structural basis of 
how Elg1 unloads PCNA from DNA and understand the role of this unloading activity in 
DNA replication and repair. 
2 Materials and Methods 
2.1 Bacterial strains and plasmids 
The pET21b-PCNA K127G was a gift from Dr. Lima. The pMCSG9 (for tagging with 
MBP) [56] and pMCSG10 [57] (for tagging with GST) were purchased from the PlasmID 
Repository (Harvard Medical School). The plasmid pMocr was obtained from Michigan 
University for better protein expression and solubility [58]. The plasmid pCDFduet-1, the 
bacterial strains Escherichia coli BL21(DE3), and BL21(DE3) pRare were commercially 
purchased from Novagen. The bacterial strain Escherichia coli DH5α was purchased from 
Thermo Fisher Scientific. All plasmids used in this study are listed in the Table 1. 
  
 
Table 1: List of proteins used in this study. 
Name Purified Protein Plasmid Name Description 
Elg1N His×6-GST-Elg1 21-150 pMCSG10-yElg1 21-150 Contains all five (2 PIP boxes, 3 SIMs) functional motifs 
Elg1L1 His×6-GST-Elg1 21-102 pMCSG10-yElg1 21-102 SIM3 deleted 
Elg1L2 His×6-GST-Elg1 21-84 pMCSG10-yElg1 21-84 SIM2 and SIM3 deleted 
Elg1L3+ His×6-GST-Elg1 33-84 pMCSG10-yElg1 33-84 Contains PIP1 and PIP2 only, slightly extended than Elg1L3 
Elg1L3 His×6-GST-Elg1 46-84 pMCSG10-yElg1 46-84 Contains PIP1 and PIP2 only 
Elg1L4 His×6-GST-Elg1 64-102 pMCSG10-yElg1 64-102 Contains PIP2 and SIM2 
Elg1L5 His×6-GST-Elg1 64-84 pMCSG10-yElg1 64-84 Contains PIP2 only 
GST-p21 His×6-GST-p21 pMCSG10-p21 PIP 
Sequence (SNASAVLQKKITDYFHPKK) of p21 PIP box is 
coded; used as a positive control for hPCNA interaction. 
PCNA Yeast PCNA K127G pET21b-PCNA K127G Contains a mutation at site 127, K to G 
Smt3 ySmt3 Δ18K19R pMCSG9-ySmt3 Δ18K19R 
First 18 amino acids were deleted and the 19th amino acid was 
mutated (K to R) 
His-Smt3 His- ySmt3 Δ18K19R  
First 18 amino acids were deleted and the 19th amino acid was 
mutated (K to R); Six histidines were directly linked to the 
protein 
1
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E1 yAos1/yUba2 1-554 
pCDFduet-yAos1  
pMcor-yUba2 1-554 
Used as E1 (activating enzyme) for SUMOylation 
E2 yUbc9 K153R pMCSG9-yUbc9 K153R 
Contains a mutation at site 153, K to R; 
Used as E2 (conjugating enzyme) for SUMOylation 
E3 ySiz1 pMocr-ySiz1 166-508 Contains the fragment of ySiz1 from 166 to 508 
Elg1 WT W20-Elg1 21-150 pMocr-yElg1 W20 Elg1 21-150 
A tryptophan was added before Elg1 protein for the 
convenience of purification 
SIM1m 
W20-Elg1 21-150  
SIM1 mutant 
pMocr-yElg1 W20 SIM1m Mutations on SIM1 
SIM2m 
W20-Elg1 21-150  
SIM2 mutant 
pMocr-yElg1 W20 SIM2m Mutations on SIM2 
SIM3m 
W20-Elg1 21-150  
SIM3 mutant 
pMocr-yElg1 W20 SIM3m Mutations on SIM3 
SIM12m 
W20-Elg1 21-150  
SIM1 and SIM2 mutant 
pMocr-yElg1 W20 SIM12m Mutations on SIM1 and SIM2 
SIM13m 
W20-Elg1 21-150  
SIM1 and SIM3 mutant 
pMocr-yElg1 W20 SIM13m Mutations on SIM1 and SIM3 
SIM23m 
W20-Elg1 21-150  
SIM2 and SIM3 mutant 
pMocr-yElg1 W20 SIM23m Mutations on SIM2 and SIM3 
SIM123m 
W20-Elg1 21-150 SIM1, 
SIM2 and SIM3 mutant 
pMocr-yElg1 W20 SIM123m Mutations on SIM1, SIM2, and SIM3 
1
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2.2 List of buffers 
Table 2: List of buffers used in this study. 
Buffer Name Used In Components 
His Buffer A MBP/GST/Mocr-tagged protein purification 25 mM Tris pH 8.0, 500 mM NaCl, 5 mM β-Me 
His Buffer B GST/Mocr-tagged protein purification 25 mM Tris pH 8.0, 500 mM NaCl, 300 mM Imidazole, 5 mM β-Me 
MBP Buffer B MBP-tagged protein purification 25 mM Tris pH 8.0, 500 mM NaCl, 10 mM maltose, 5 mM β-Me 
Dialysis Buffer Protein purification 25 mM Tris pH 8.0, 200 mM NaCl, 0.5 mM EDTA, 5 mM β-Me 
Anion Buffer A MBP/GST/Mocr-tagged protein purification 25 mM Tris pH 8.0, 5 mM β-Me 
Anion Buffer B MBP/GST/Mocr-tagged protein purification 25 mM Tris pH 8.0, 1 M NaCl, 5 mM β-Me 
Cation Buffer A Protein purification 25 mM Tris pH 8.0, 5 mM β-Me 
Cation Buffer B Protein purification 25 mM Tris pH 8.0, 0.1 M NaCl, 5 mM β-Me 
GST pull-down buffer GST pull-down assay 
20 mM Hepes pH 7.5, 100 mM NaCl, 5% glycerol, 1 mM EDTA,  
5 mM β-Me 
GST pull-down elution 
buffer 
GST pull-down assay 
20 mM Hepes pH 7.5, 100 mM NaCl, 10 mM reduced glutathione, 
5% glycerol, 1 mM EDTA, 5 mM β-Me 
ITC buffer ITC 20 mM Hepes pH 7.5, 100 mM NaCl, 5 mM β-Me 
NMR buffer NMR  20 mM Hepes pH 7.5, 100 mM NaCl, 10% D2O 
1
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2.3 Cloning of constructs for expression 
We first cloned Elg1 N-terminus from 1 to 150 and hoped it could be used as the wild-
type Elg1. However, we found this fragment have low expression and solubility. 
Therefore, we designed and tested more constructs in various lengths. The construct 
that expressed Elg1 21-150 with an extra W ahead of the protein was suitable for our 
purposes. This construct was used as the wild-type, and it was altered to generate 
various Elg1 SIM mutants. These mutants contain different combinations of SIM 
mutations, and M-PIPE cloning was used to introduce point mutations in the desired 
sites [59], where the hydrophobic amino acids of SIM(s) were mutated into alanines. 
The sequences of the primers used to introduce mutations into SIMs are listed in 
Appendix A. 
In brief, each pair of primers requires approximately 15 bp of complementary sequences 
at the 5’ primer end. The 3’ primer end must be complementary to the flanks of the 
mutation site [60]. First, PCR reactions were set up to create a single SIM mutant. The 
reaction utilized Q5 polymerase to amplify and the extension of 25 cycles was 
conducted. PCR products were checked on a 1% agarose gel. After we confirmed that 
the products were of the proper size, DpnI digestion was used to remove the methylated 
original templates. Digested samples were transformed into DH5α competent cells via 
the heat shock method. Single clones were picked to grow in a 5 ml LB media, and 
minipreps were performed to extract the plasmids. The plasmids later were sent for 
sequencing to confirm the correct mutations. By using correct Elg1 SIM single mutants 
as templates, mutants containing double SIMs mutations and triple mutations were 
obtained in similar protocols. All plasmids were sent for sequencing to confirm correct 
mutations. 
To investigate the role of different SIMs within the Elg1 N-terminus, we also generated 
the constructs for expression and purification of His-Smt3, using the pMocr Smt3 
Δ18K19R as the template. Similar protocol and primer design were used as above. The 
primers used for mutagenesis were designed to remove the Mocr tag and TEV cutting 
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site. We mutated out the DNA code for the Mocr tag and TEV cutting site. This would 
directly link the protein with the 6 histidines for the convenience of purification. The 
primers were synthesized by UWO Oligo Factory (Appendix A). 
2.4 Expression and purification 
2.4.1 Expression and purification of yeast PCNA 
The plasmid for expressing yeast PCNA was transformed into BL21(DE3) pRare 
competent cells via the heat shock method. All PCNAs in the following descriptions 
mean yeast PCNA unless stated otherwise. The transformants were later selected with 
100 µg/mL ampicillin and 25 µg/mL chloramphenicol. Fresh colonies were transferred 
to LB media. After the cell culture reached an OD600 of 0.7, 1 mM IPTG was to induce 
the protein expression at 16 °C. Cells were harvested after overnight growth and frozen 
in -80°C for future usage. 
The purification of yeast PCNA includes ammonium sulfate precipitation and two 
rounds of anion exchange chromatography [61]. Frozen cells were thawed with warm 
water and suspended in His Buffer A (Table 2), with 1mM protease inhibitor, 
phenylmethylsulfonyl fluoride (PMSF). Cells were lysed with the homogenizer and 
ultracentrifuged at 48,380 g for 30 minutes to obtain soluble protein. The soluble 
fractions of PCNA were then gradually spiked with ammonium sulfate to 45% 
saturation in an ice water bath. The solution was centrifuged and the supernatant was 
collected. After centrifugation at 12,000 g for 30 minutes, the new supernatant was 
separated and spiked to 75% saturation with more ammonium sulfate. The precipitant 
was dissolved with Dialysis Buffer (Table 2) and put into dialysis overnight. The 
dialyzed protein was directly loaded onto the Q columns (GE Healthcare). A gradient 
of Anion Buffer B (Table 2) (20% to 65% in 12 column volumes) was employed, and 
the protein was eluted at the conductivity of approximately 32 ms/cm. The fractions 
containing the protein of interest (checked with SDS-PAGE) were pooled and 
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concentrated with a 10 kDa cut-off concentrator at a speed of 2,000 g. The concentrated 
protein was flash frozen and stored in -80°C for future assay. 
2.4.2 Expression and purification of SUMOylation enzymes and SUMO 
a) E1 enzyme (yAos1/yUba2 1-544)  
Plasmids expressing yAos1 and yUba2 1-544 were co-transformed into BL21(DE3) 
pRare competent cells via the heat shock method and selectively grown in 100 µg/ml 
ampicillin, 25 µg/ml chloramphenicol, and 50 µg/ml streptomycin. Expression was 
induced at OD600 0.7-0.8 for 16°C overnight, and cells were frozen for storage. The 
targeted proteins were purified via the same protocol as for wild-type Elg1 purification 
(described in the later section 2.4.4). 
b) E2 enzyme (yUbc9 K153R) 
The plasmid to express yUbc9 was transformed using the same heat shock method as 
yeast PCNA. The cells were induced at OD600 0.7-0.8 for 30°C overnight, then collected 
and frozen for storage. Expressed protein was purified using a similar protocol as for 
wild-type Elg1 purification (described in the later section 2.4.4), with a change of using 
cation exchange chromatography (SP columns from GE Healthcare), instead of anion 
exchange chromatography. 
c) E3 enzyme (ySiz1 166-508) 
The plasmid to express ySiz1 was transformed, and the cells were grown in the same 
conditions as for the E2. Expressed protein was purified by using the same protocol as 
for wild-type Elg1 purification (described in the later section 2.4.4). 
d) SUMO (Smt3 Δ18K19R, His-Smt3 Δ18K19R) 
The plasmid to express Smt3 Δ18K19R was transformed, and the cells grew in the same 
conditions as the E2. Expressed protein was purified with MBP affinity and anion 
exchange chromatography. After the soluble protein was obtained through the same 
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procedures as for Elg1, the sample was loaded onto MBP columns (GE Healthcare) and 
eluted with MBP Buffer B (Table 2). Those fractions containing the protein of interest 
were pooled, and a molar ratio of 1:40 TEV to protein was used for digestion, while 
dialysis occurred overnight. The digested and dialyzed sample was run through the 
MBP columns. The protein would remain in the flow through. The sample was then 
diluted to approximately 100 mM NaCl for anion exchange chromatography. A 
gradient of Anion Buffer B (10% to 30% in 12 column volumes) was employed. 
Fractions were checked by SDS-PAGE analysis. The fractions containing the protein 
of interest were pooled and concentrated with a 5 kDa cut-off concentrator with a speed 
of 2,000 g. The concentrated protein was flash frozen and stored in -80°C for future 
assay. 
The plasmids to express His-Smt3 Δ18K19R were transformed and induced in the same 
conditions as for Smt3 Δ18K19R. Expressed protein was purified with nickel affinity 
chromatography and anion exchange chromatography as GST-fused Elg1 fragments 
(described in 2.4.3). The purified protein was concentrated to over 10 mg/ml and flash 
frozen for future assays. 
2.4.3 Expression and purification of GST-fused Elg1 fragments 
All plasmids for expressing GST-fused fragments were transformed in the same way as 
for PCNA. The cells were induced at OD600 0.7-0.8 for 25°C overnight, then collected 
and frozen for storage. The protein was purified via nickel affinity chromatography and 
anion exchange chromatography.  
Cells were lysed and centrifuged as described above as purification of yeast PCNA. 
The soluble protein underwent nickel affinity chromatography. Fractions containing the 
protein of interest were obtained via the same procedures as for Elg1 WT (in 2.4.4). 
Instead of setting up the protein for dialysis and digestion, the protein was directly 
diluted to approximately 100 mM NaCl and loaded onto the Q columns, followed by a 
gradient of Anion Buffer B (10% to 30% in 12 column volumes). The fractions 
containing the protein of interest (checked with SDS-PAGE) were pooled and 
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concentrated with a 10 kDa cut-off concentrator with a speed of 2,000 g. The protein 
was concentrated to over 20 mg/ml and stored with 50% glycerol (final protein 
concentration would be over 10 mg/ml) at -20°C for pull-down assays. 
2.4.4 Expression and purification of Elg1 WT and Elg1 SIM mutants  
Procedures to express Elg1 WT and Elg1 SIM mutants were the same as used for PCNA 
transformation. The transformants were induced with 1 mM IPTG when OD600 reached 
0.4-0.6. The cells were grown at 37°C for 3 hours and collected for storage. Nickel 
affinity chromatography and anion exchange chromatography were applied to purify 
Elg1 WT and Elg1 mutant proteins.  
Cells were lysed with the homogenizer, and the soluble protein was collected as 
described above. The samples were loaded onto the nickel columns (GE Healthcare) 
and washed with 10 column volumes of washing buffer that contained extra 15 mM 
imidazole in His Buffer A, followed by elution via His Buffer B (Table 2). Fractions 
that contained the protein of interest were pooled together, and a ratio of 1:40 TEV to 
protein was used to remove the tag while the sample underwent dialysis in the Dialysis 
Buffer (Table 2) overnight. After digestion and dialysis, the samples were run through 
the nickel columns again, and the protein of interest remained in the flow through. The 
flow-through samples were diluted to approximately 100 mM NaCl and loaded onto Q 
columns. The protein was eluted with a gradient of Anion Buffer B (10% to 30% in 12 
column volumes). The fractions containing the protein of interest (checked with SDS-
PAGE) were pooled and concentrated with a 10 kDa cut-off concentrator with a speed 
of 2,000 g. The concentrated protein was flash frozen and stored in -80°C for future 
assays. 
2.5 SUMOylation of PCNA 
Before setting up the SUMOylation reaction, the concentrations of the proteins were 
measured via the Bradford method, and the volume of protein needed for this reaction 
was calculated accordingly. Proteins - 15 µM PCNA, 60 µM Smt3 Δ18K19R, 90 nM 
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yAos1/yUba2 1-544 (E1), 300 nM Ubc9 K153R (E2), and 2 µM Siz1 166-508 (E3) - 
were mixed for SUMOylation [26]. The final buffer condition for the SUMOylation 
was 50 mM pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 mM TCEP, 5% glycerol, and 
0.01% NP-40. A total of 2 mM ATP was added to initiate the reaction, followed by 
incubation at room temperature for 30 minutes. The reaction solution was later 
supplemented with excess EDTA to slow down the reaction and with NaCl to 
approximately 250 mM for loading onto the Q columns. The protein was eluted with a 
gradient of Anion Buffer B (25% to 65% in 12 column volumes). The fractions 
containing sufficiently pure sPCNA (checked with SDS-PAGE) were pooled and 
concentrated with a 30 kDa cut-off concentrator with a speed of 2,000 g. The 
concentrated protein was flash frozen and stored in -80°C for future experiments. 
2.6 GST pull-down assay 
GST-pull down assays were employed to investigate the roles of different functional 
motifs in the interaction with PCNA. Purified GST-tagged Elg1 protein fragments (bait) 
(200 μl, 1 mg/ml) were immobilized onto 20 μl of glutathione-sepharose beads. Also, 
GST and GST-p21 of the same concentration were used in this assay as the negative 
control and positive control (with hPCNA), respectively. After immobilizing the bait 
proteins, the beads were washed 3 times with 200 μl GST pull-down buffer (Table 2) 
to remove unbound protein. The prey proteins (Smt3, PCNA, sPCNA and hPCNA) 
were diluted with binding buffer to a molar concentration that was slightly over that of 
the bait. The preys were then added to the beads for incubation on ice. After an hour, 
the beads were washed 3 times with 200 μl binding buffer to remove unbound prey 
proteins. The bound proteins were eluted with 50 μl of GST pull-down elution buffer 
(Table 2). Supernatants were collected after centrifugation and resolved by SDS-PAGE. 
To explore the role of SIMs, GST-tagged Elg1 protein fragments were used in pull-
down assays with Smt3. Similar procedures were used as before, but with a higher 
protein concentration and higher molar ratio. The bait was prepared to 2 mg/ml, and the 
ratio of the prey’s molar concentration to the concentration of the bait was increased to 
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3-fold. After using similar procedures as for investigating the interactions with PCNA 
and sPCNA of incubation, washing, and eluting, the eluted proteins were resolved on 
SDS-PAGE gels. 
2.7 Isothermal titration calorimetry 
ITC experiments were performed with proteins that were exchanged into the ITC buffer 
(Table 2) via size exclusion chromatography. ITC measurements were performed on 
the Nano ITC calorimeter (TA Instruments) at 25°C with a stirring speed of 250 rpm.  
To start a test run for investigating the interaction between Elg1 and PCNA, 830 µM 
PCNA were titrated into 79 µM GST Elg1L3+. The titration was conducted in 34 x 1.5 
µl injections, following a 0.5 µl initial injection. Control experiments were conducted 
by titrating sPCNA into the ITC buffer under the same experimental settings. 
Experimental data were analyzed by Nanoanalyze by subtracting the signals from 
control experiments and fitting into the independent binding model.  
To investigate the role of SIMs in the interaction with sPCNA, 406 µM sPCNA were 
titrated into Elg1 WT and various Elg1 SIM mutants (60 µM) in 34 x 1.5 µl injections, 
following a 0.5 µl initial injection. Control experiments were conducted by titrating 
sPCNA into the ITC buffer under the same experimental settings. The same fitting 
strategy was performed to fit the data. 
To investigate how mutations on SIMs affect the interaction with Smt3, Elg1 WT (0.72 
mM) and Elg1 single mutants (0.56 mM Elg1 SIM1m, 0.78 mM Elg1 SIM2m, and 0.68 
mM Elg1 SIM3m) were titrated into 0.1 mM His-Smt3. All titration experiments were 
performed with 26 x 2.0 µl injections, following a 0.5 µl initial injection. Control 
experiments were performed by titrating the same concentration of Elg1 single SIM 
mutants into the ITC buffer. As for the fitting strategy, we assumed that all three SIMs 
identically bind to the Smt3. Therefore, we multiplied the Elg1 concentration by 3 as 
the effective concentration when we fitted the titration data of Elg1 WT, and we 
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multiplied the Elg1 concentration by 2 when we fitted the titration data of Elg1 single 
SIM mutants, assuming that mutations on the SIMs abolished the binding ability. After 
the Elg1 concentration was multiplied, we fitted the data with an independent binding 
model same as above. 
2.8 NMR spectroscopy 
NMR spectroscopy was performed to further investigate how Elg1 interacts with Smt3. 
The 15N labeled Smt3 was expressed in M9 minimal media that contains 15NH4Cl as 
the sole nitrogen source and was induced overnight. Unlabeled Elg1 WT and 15N 
labeled Smt3 were purified as described in previous sections.  
Purified Smt3 and Elg1 WT was exchanged into NMR buffer (Table 2) via size 
exclusion chromatography. Two samples for NMR were prepared by directly utilizing 
the exchanged sample. The sample containing only Smt3 was prepared by mixing the 
same volume of the Smt3 sample and the buffer, followed by adding D2O (10% final). 
A total of 167 μM 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) was added as an 
internal reference, and 3 mM imidazole was added as an internal pH indicator. The final 
concentration of Smt3 in the NMR sample was 61 µM. The other sample was prepared 
by mixing the same volume of the Smt3 sample and the Elg1 sample, followed by 
adding the same additives, which contain the highest Elg1: Smt3 ratio (5.5:1). Other 
samples with different ratios were made by mixing these two samples or their mixture 
with the same volume of Smt3 sample.  
The samples were equilibrated on the Varian INOVA 600-MHz NMR spectrometer for 
15 minutes after loading, and the signal was collected at 25°C for 30 minutes. The NMR 
spectrum was acquired with the following parameters: number of complex points= 
1022, sweep width of 7002.8 Hz in 1H and 1700 Hz in 15N, 64 increments in second 
dimension and 32 scans for each increment. All data were processed using NMRPipe 
[62] and plotted using NMRViewJ [63]. Smt3 was previously assigned by NMR 
spectroscopy [64], and this was used to assign signals in the current spectra according 
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to the signals’ relative positions. We presume the three SIMs are identical regarding 
their abilities to bind Smt3. Therefore, we set the n value as 3.0 and fit all data sets with 
shared Kd. The chemical shifts to calculate Kd are listed in Table 6. The curves to 
determine the Kd were plotted with the equations below:  
𝑌 = 𝑛 ∗ 𝐵 ∗
𝑃𝐿
𝑃𝑡
 
𝑃𝐿 =
(𝑛𝑃𝑡 + 𝑛𝑋 + 𝐾𝑑) − √(𝑛𝑃𝑡 + 𝑛𝑋 + 𝐾𝑑)2 − 4𝑛2𝑋𝑃𝑡
2𝑛2
 
 (Y – chemical shift changes; PL - protein-ligand complex concentration; Pt - total 
protein concentration; X - added ligand concentration; Kd - dissociation constant (same 
units as Pt); n - the number of identical binding sites on ligand; B – normalization factor 
(a constant that used to adjust the data to the spectrum range))  
The equation is used to measure changes in the chemical shift with the equation below: 
𝛥𝐶𝑠𝑝 = √(∆𝛿( 𝐻1 ))2 + (0.2 ∗ ∆𝛿( 𝑁15 ))2” 
The ΔCsp represents the overall chemical shift perturbations, ∆𝛿( 𝐻1 )  represents the 
chemical shift on 1H, and ∆𝛿( 𝐻1 ) represents the chemical shift on 15N. Those data 
were utilized to map the interacting surface. The basic structures were from PDB 3V62 
[26] (contains the structure of Srs2 SIM binding to Smt3) and 2EKE [65] (contains the 
structure of yUbc9 binding to Smt3). The interacting surface of Smt3 was mapped in 
Pymol via locating the positions of the residues that have chemical shifts that are larger 
than average. 
2.9 Crystallization 
Two strategies were used to screen for crystals. One is to directly mix Elg1 fragments 
and PCNA. The proteins used for crystallization were exchanged in the ITC buffer via 
size exclusion chromatography. The protein complex of PCNA and Elg1 was prepared 
by directly mixing the two proteins at a ratio of 1: 1.2 and was concentrated for usage. 
Both hanging drop and sitting drop vapor diffusion were used to screen with 
commercially available and house-made crystallization kits.  
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Additionally, we used the synthesized peptide that contains the PIP box to complex 
PCNA/sPCNA for screening. The sequence of the synthesized peptide is 
DSVIFLNHSVVKPIEAVSK, which contains the proposed PIP box in Parnas et al. [2]. 
Unfortunately, the peptide is difficult to dissolve in aqueous solution. For this reason, 
we adjusted the pH of the peptide solution to the same as the buffer after dialysis. We 
directly mixed the dialyzed peptide with PCNA/sPCNA in an excess ratio 
(protein:peptide=1:3). The protein-peptide mixtures were used to screen with 
commercially available and home-made crystallization kits.  
3 Results 
3.1 Interactions between Elg1 and PCNA/sPCNA 
3.1.1 Construct design of Elg1 SIM mutants 
Several Elg1 SIM mutants have been generated to investigate the roles of different 
motifs within the Elg1 N-terminal fragment. To clone plasmids that have SIM mutations 
within Elg1 N-terminus, the M-PIPE cloning method was employed using the Elg1 WT 
construct as the template. The sequences of the primers used to generate Elg1 SIM 
mutants are listed in Appendix A, and the primers were synthesized by UWO Oligo 
Factory. Three sets of primers were designed to mutate SIM1, SIM2, and SIM3. We 
mutated the hydrophobic amino acids of SIMs into alanines and kept the acidic stretch 
(mutated sequences are shown in Figure 6). All 7 versions of SIM mutants were 
constructed via M-PIPE cloning. These detailed protocols are already described in the 
Materials and Methods.  
3.1.2 Protein expression and purification  
3.1.2.1 Expression and purification of yeast PCNA 
The construct of PCNA we used has a mutation that changes K into G at the site of 127. 
That was made to abolish the extent of SUMOylation on site 127 to obtain more sPCNA 
with SUMOylation at K164. Yeast PCNA purification procedures include ammonium  
  
 
 
Figure 6: Construct design of Elg1 SIM mutants. 
Panel A shows the order of five putative motifs in the Elg1 N-terminus, and panel B presents the mutations on the Elg1 WT with various combinations. 
The exact regions of SIMs are outlined with the purple boxes. The mutations on SIM1, SIM2, and SIM3 are highlighted in the yellow, light blue, and 
green, respectively. 
2
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Figure 7: Purification of yeast PCNA. 
SDS-PAGE analysis of purification samples after each step of chromatography. The 
position of yeast PCNA on SDS-PAGE is indicated with arrows. 
A) Ammonium sulfate precipitation to purify yeast PCNA. Cell lysis (2 lanes to left of lane 
1), soluble protein (to left of lane 1), 45% ammonium sulfate saturation supernatant (lane 
1), 45% ammonium sulfate saturation precipitation (lane 2), 75% ammonium sulfate 
saturation supernatant (lane 3), and 75% ammonium sulfate saturation precipitation (lane 
4) are indicated.  
B) The first round of anion exchange chromatography using Q column.  
C) The second round of anion exchange chromatography using Q column.  
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sulfate precipitation and two rounds of anion exchange chromatography.  
As seen in Figure 7A, the dominant band in the cell lysis showed the position of PCNA on 
SDS-PAGE (slightly below 31.0 kDa marker). For ammonium sulfate precipitation, most 
PCNA remained in the supernatant (lane 1), while a lot of contaminants were precipitated 
with 45% ammonium sulfate saturation and removed via centrifugation (lane 2). With the 
addition of ammonium sulfate at 75% saturation in the second precipitation, most PCNA 
was precipitated (lane 3). Two rounds of anion exchange chromatography were later 
applied to further purify the protein (Figure 7B and 7C).  
The PCNA starts to elute when the conductivity reached 36 ms/cm. Fractions that contain 
sufficiently pure PCNA were pooled. The yield of PCNA was over 100 mg for a one-liter 
culture. The PCNA has a molecule weight of approximately 28.9 kDa, and its purity after 
purification was checked with SDS-PAGE (Figure 8). 
3.1.2.2 Expression and purification of SUMOylation enzymes 
These enzymes were expressed and purified in various conditions as described in the 
section 2.4.2. The procedures to purify E1 and E3 includes nickel affinity chromatography, 
digestion and dialysis, a second nickel affinity chromatography, and anion exchange 
chromatography. The procedures to purify E2 are similar, with the last step changed to 
cation exchange chromatography, due to E2’s high overall PI. All proteins were 
concentrated to over 10 mg/ml and marked with their molar concentration for the 
convenience of calculation. It is also critical to note the NaCl concentration in which the 
proteins were kept, for the SUMOylation reaction requires approximately 100 mM NaCl to 
avoid slow and insufficient SUMOylation. Those proteins-yUba2 1-544 (61.3 kDa) and 
yAos1 (39.3 kDa), yUbc9 K153R (17.9 kDa), and ySiz1 166-508 (38.8 kDa)- were resolved 
on SDS-PAGE after purification to check purity (Figure 8). 
3.1.2.3 Expression and purification of Smt3 Δ18K19R 
The plasmid pMCSG9-Smt3 Δ18K19R was transformed and induced as described in the  
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Figure 8: SDS-PAGE analysis of SUMOylation enzymes and substrates. 
The quality of purified SUMOylation enzymes and substrates were checked in this SDS-
PAGE.  Protein  yUba2 1-544 (first lane upper band, 61.3 kDa) , yAos1 (first lane lower 
band, 39.3 kDa), yUbc9 K153R (17.9 kDa), ySiz1 166-508 (38.8 kDa), Smt3 Δ18K19R 
(9.3 kDa) and  PCNA (28.9 kDa)  are presented. All proteins were over 95% pure after 
purifications.
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Materials and Methods. Expressed protein was purified with MBP affinity and anion 
exchange chromatography. Fractions that contain sufficiently pure Smt3 Δ18K19R was 
pooled after anion exchange chromatography and concentrated for future assays. Protein 
Smt3 Δ18K19R (9.3 kDa) was over 95% pure after purification, and it ran at a position of 
approximately 14.4 kDa on the SDS-PAGE gel (Figure 8). 
3.1.2.4 Expression and purification of GST-tagged Elg1 fragments 
As described in the Materials and Methods, these recombinant proteins were expressed in 
BL21(DE3) pRare and purified by nickel affinity chromatography and anion exchange 
chromatography. The representative purification (GST Elg1L1) is shown in Figure 9.   
Each Elg1 N-terminal fragment was expressed together with a GST tag with 6 histidines 
added before the GST. Therefore, we can use the nickel columns to purify these proteins. 
After washing with the buffer that has a low concentration of imidazole, the protein eluted 
with His Buffer B (Figure 9). The eluted sample (contains approximately 500 mM NaCl) 
was diluted to approximately 100 mM NaCl and directly loaded onto Q HP columns (GE 
Healthcare) for anion exchange chromatography. The protein eluted with an increasing 
gradient of Anion Buffer B (Figure 9). Different Elg1 fragments eluted at different 
conductivities, within the range of 16 to 24 ms/cm. All purified proteins were concentrated 
and kept in -20°C with 50% glycerol (final concentration), while the proteins were kept 
over 10 mg/ml at final concentration. Normally, the yield of one fragment would be at least 
6 mg for a one-liter culture. The purity of the protein was checked with SDS-PAGE during 
purification. 
3.1.2.5 Expression and purification of Elg1 WT and Elg1 SIM mutants 
As described in the Materials and Methods, the Elg1 WT and Elg1 mutant protein were 
expressed in BL21(DE3) pRare and purified by nickel affinity chromatography, digestion 
and dialysis, second nickel affinity chromatography and anion exchange chromatography. 
Shown in Figure 10A, the dominant band indicated the position of expressed protein 
(Elg1L1), and SDS-PAGE was used to check protein purity after nickel affinity chromatog- 
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Figure 9: Representative purification of GST-tagged Elg1 fragments. 
This purification utilized cells expressing GST-fused Elg1L1. A) SDS-PAGE analysis of 
nickel affinity chromatography fractions. Cell lysis, soluble protein, flow through (marked 
as FT in the figure), wash, and fractions of elution are indicated; B) Anion exchange 
chromatography via Q column. The protein was over 90% pure after purification. 
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Figure 10: Representative purification of Elg1 SIM mutants. 
This figure shows the purification of protein Elg1 SIM1m. 
A) Nickel affinity chromatography of Elg1 SIM1m using the nickel column. Expressed 
tagged protein is indicated with the arrow; B) The second nickel affinity chromatography 
of Elg1 SIM1m. The lane “BD” represents the sample before digestion and dialysis; the 
lane “AD” represents the sample after digestion and dialysis. After loading onto the nickel 
columns, the protein of interest stayed in the flow through (indicated as “FT”); C) The anion 
exchange chromatography of Elg1 SIM1m using Q columns. The position of Elg1 SIM1m 
is indicated with arrow. The protein was over 95% pure after purification.  
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-raphy. Fractions that have protein of interest were pooled and put into dialysis, with the 
addition of TEV to cut off the tag. The digested sample was loaded onto the nickel columns 
that were pre-equilibrated with the buffer that contains extra 15 mM imidazole. The flow-
through sample was subjected to the anion exchange chromatography (Figure 10C). 
Normally, we can get approximately 6 mg from a one-liter culture. The purified mutant 
proteins tend to aggregate in high protein concentrations compared to Elg1 WT. Therefore, 
the mutants were kept with cations via the flash frozen method. The protein was refreshed 
and exchanged into the required buffer when they were needed. 
3.1.3 SUMOylation of PCNA 
Proteins - 15 µM PCNA, 60 µM Smt3, 90 nM yAos1/yUba2 1-544 (E1), 300 nM yUbc9 
K153R (E2), and 2 µM ySiz1 166-508 were mixed together in the SUMOylation buffer. 
The reaction was started with the addition of ATP (2 mM for final concentration). Different 
time points were tested to obtain the sufficiently pure sPCNA (Appendix B). Excess EDTA 
was added to the SUMOylation products to slow down the reaction, and the sample was 
centrifuged or filtered to remove any precipitation. Shown in Figure 11, the sample was 
purified by anion exchange chromatography, and sPCNA’s purity was checked by SDS-
PAGE. It is noteworthy that the SUMOylation products are not 100% pure and contains a 
small amount of unmodified PCNA and some double-SUMOylated PCNA. Normally, 20ml 
of reaction sample would produce about 9 mg of sPCNA. Protein sPCNA has a molecule 
weight of approximately 37.9 kDa, and it ran at the slightly lower position than 45.0 kDa 
on SDS-PAGE gels. 
3.1.4 GST pull-down assay 
To evaluate the functions of the motifs in the Elg1 N-terminus, GST pull-down assays were 
performed by using different GST-tagged Elg1 fragments containing various combinations 
of the protein binding motif (Figure 12A). Those fragments are named based on their 
lengths, such as Elg1L1 (longest, 21-102) and Elg1L5 (shortest, 64-84). The pull-down 
assay with GST as bait was performed as the negative control, and the pull-down assay that  
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Figure 11: Purification of SUMOylated PCNA. 
The lane marked “No ATP” represents the sample taken before the addition of ATP; the 
lane marked “0min” represents the sample taken right after the addition of ATP to stimulate 
SUMOylation; the lane marked “30min” represents the sample taken after 30min of room 
temperature incubation; the lane marked “Load” represents the sample before being loaded 
onto the Q column; “FT” and “Elution” represent the flow through of the Q column during 
sample loading and collection of eluted fractions, respectively. The positions of double-
SUMOylated PCNA, sPCNA, PCNA, and Smt3 are marked on the right.  
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used GST-p21 as bait and hPCNA as prey was set up as the positive control (Figure 12B 
and 12C).  A summary of the pull-down results with different Elg1 fragments is listed in 
Table 3. From the observation of the output lanes that used Smt3 as prey, Smt3 showed no 
binding with Elg1 N-terminus in this assay. This outcome may be a result of low binding 
affinity,  
suggesting that a need for a higher molar concentration of prey (Smt3 in this case), or GST 
pull-down assay is not suitable for assessing Elg1 SIMs’ binding abilities with Smt3.  
Only one of the Elg1 N-terminal fragment pull-down assays showed a faint band (marked 
red in Figure 13A) that indicated interaction with PCNA on SDS-PAGE analysis. The 
fragment is Elg1L3 that contains no SIMs. Even though the band is weak, it still confirms 
the Elg1 N-terminus’ binding ability with PCNA and also indicates low binding affinity 
between Elg1 and PCNA under normal conditions. However, other Elg1 N-terminal 
fragments that have more functional motifs than just PIP boxes did not show interaction 
with PCNA. The presence of SIM motifs in those longer constructs results in reduced 
interactions with PCNA, suggesting the SIMs may play an inhibitory role in the interaction 
with PCNA. Additionally, we confirmed the Andy Liu’s results with our method that eluting 
proteins off the beads. Relatively strong PCNA binding was shown with the construct 
Elg1L3+ (Figure 14). Moreover, several Elg1 N-terminal fragments showed the ability to 
bind sPCNA, which is Elg1N (marked in blue in Figure 13A left), Elg1L3 (marked in blue 
in Figure 13A right) and Elg1L1 (marked in blue in Figure 13B). Comparing the detected 
sPCNA bands from Elg1N (21-150) and Elg1L1 (Elg1 21-102), a similar relative intensity 
is seen, suggesting SIM3, which is located between 103 and 150, may have subtle effects 
in the interaction with sPCNA. In addition, deletion of more SIMs results in no detection 
of sPCNA in GST pull-down assays, which indicates one single SIM may be not enough to 
promote the binding with sPCNA. 
3.1.5 ITC 
After the confirmation of the interactions between the Elg1 N-terminus and PCNA/sPCNA 
with GST pull-down assays, we attempted to further investigate these interactions. ITC 
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Figure 12: Structure of Elg1 fragments and GST pull-down controls. 
A) The bar diagram represents the functional motifs of the Elg1 N-terminus that exist in 
the Elg1 constructs used in this assay. The missing motifs were deleted from the fragment. 
B) Positive control experiment performed in this assay. The position of GST-p21 and 
hPCNA are indicated.  
C) Negative control experiments performed in this assay. GST was used as the bait, while 
Smt3, PCNA, sPCNA, and hPCNA are used as prey. The result shows GST alone cannot 
bind to any of the preys. 
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Figure 13: GST pull-down assays with various Elg1 N-terminal fragments. 
A) Smt3, PCNA, and sPCNA as the prey and Elg1N (left)/ Elg1L3 (right) as the bait; B) 
Smt3, PCNA, and sPCNA as the prey and Elg1L2 (left)/ Elg1L1 (right) as the bait; C) Smt3, 
PCNA, and sPCNA as the prey and Elg1L5 (left)/ Elg1L4 (right) as the bait. Positive 
detections in the outputs are indicated with the red arrow for PCNA and the blue arrow for 
sPCNA.
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Figure 14: GST pull-down assay with Elg1L3+. 
We used a different method from the one in Andy’s thesis and confirm the results.  Protein 
Elg1L3+ was used as the bait, and Smt3, PCNA, and sPCNA were used as the prey. Positive 
detection in the outputs is indicated with a red arrow for PCNA and a blue arrow for 
sPCNA. The results showed Elg1L3+ could interact with PCNA and sPCNA, but not with 
Smt3.
  
 
                                         Table 3: A summary of GST pull-down assay results. 
 
Short Name Bait Motifs 
Prey 
Smt3 PCNA sPCNA 
GST GST NA - - - 
Elg1N Elg1 21-150 SIM1/PIP1/PIP2/SIM2/SIM3 - - + 
Elg1L1 Elg1 21-102 SIM1/PIP1/PIP2/SIM2 - - + 
Elg1L2 Elg1 21-84 SIM1/PIP1/PIP2 - - - 
*Elg1L3+ Elg1 33-84 PIP1/PIP2 - + + 
Elg1L3 Elg1 46-84 PIP1/PIP2 - + + 
Elg1L4 Elg1 64-102 PIP2/SIM2 - - - 
Elg1L5 Elg1 64-84 PIP2 - - - 
 
                                                    All Elg1 fragments contain a GST tag at the N-terminus.  
                                         sPCNA is the short name of SUMOylated PCNA. 
                                         * The referred results were from Andy Liu’s thesis, and these results were confirmed by us. 
4
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experiments were performed on the NanoITC. For an ITC titration, the energy absorbed or 
given off by protein-protein interactions are detected, and the analysis program can 
determine the thermodynamic data, such as the dissociation constant (Kd), stoichiometry 
(N), enthalpy (ΔH), and entropy (ΔS).  
During test runs, the titration between the Elg1 N-terminus and PCNA was difficult to make 
an accurate analysis. We tried to titrate 830 µM PCNA into 79 µM Elg1L3+ (Appendix C). 
The construct Elg1L3+ (33-84) showed relatively strong binding with PCNA in GST pull-
down assays among all constructs tested (Figure 14). Therefore, we used this construct for 
the test run. Although enough heat signals were produced for detection in ITC, an apparent 
Kd of over 424 µM was determined after analysis, which was significantly larger than the 
concentration of PCNA in the cell. Therefore, the accuracy of this analysis is questionable. 
Alternatively, we tried to characterize the interaction between the Elg1 N-terminus and 
sPCNA. The titration of sPCNA to Elg1 and titration of Elg1 to sPCNA were both tested. 
We observed that the titration of Elg1 to sPCNA tends to produce aggregation (samples 
became turbid), which reduced the effective protein concentration in binding. Therefore, 
the characterization of the binding was conducted via titration of sPCNA to Elg1. Shown 
in Figure 15A, 406 µM sPCNA were titrated into 60 µM Elg1 WT that contains all 
functional motifs for the binding at 25°C with a stirring speed of 250 rpm. The control 
experiment was performed by titrating the same concentration of sPCNA into the ITC 
buffer. The experimental data were subtracted with the control experiment and fitted using 
a one-site binding model. The main parameters of binding from the analysis are listed in 
Table 4. The apparent Kd for this titration between Elg1 WT and sPCNA is 8.23±3.31 µM, 
with an N value of 1.122±0.073, ΔH of -13.07±1.18 kcal/mol, ΔS of -20.57 kcal/mol·K. 
To investigate the effects of SIMs on the interactions, constructs containing various 
combinations of SIMs mutations were made. Protein 406 µM sPCNA was titrated into 60 
µM Elg1 SIM mutants that have various combinations of SIM mutations. The same setting 
as for Elg1 WT was employed to perform these titrations. However, it appears that Elg1  
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Figure 15: ITC titrations between sPCNA and Elg1/Elg1 SIM mutants. 
All titrations were performed at 25°C with a stirring speed of 250 rpm. The control 
experiments were shown in green, and the protein to protein titration experiments were 
shown in red. A) 406 µM sPCNA titrated into 60 µM Elg1 WT; B) 406 µM sPCNA titrated 
into 60 µM SIM1m; C) 406 µM sPCNA titrated into 60 µM SIM2m; D) 406 µM sPCNA 
titrated into 60 µM SIM3m. 
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Continued Figure 15: ITC titrations between sPCNA and Elg1/ Elg1 SIM mutants. 
All titrations were performed at 25°C with a stirring speed of 250 rpm. The control 
experiments were shown in green, and the protein to protein titration experiments were 
shown in red. E) 406 µM sPCNA titrated into 60 µM SIM12m; F) 406 µM sPCNA titrated 
into 60 µM SIM13m; G) 406 µM sPCNA titrated into 60 µM SIM23m; H) 406 µM sPCNA 
titrated into 60 µM SIM123m. 
 
 
 
 
                          Table 4: A summary for ITC titrations between sPCNA and Elg1 
 
 Protein in Cell 
Protein in 
Syringe 
N Kd(µM) ΔH(kcal/mol) ΔS(kcal/mol·K) 
A Elg1 WT sPCNA 1.122±0.073 8.23±3.31 -13.07±1.18 -20.57 
B SIM1m sPCNA 0.950±0.086 12.13±4.07 -12.72±1.72 -20.18 
C SIM2m sPCNA 0.850±0.060 8.87±3.36 -13.88±1.58 -23.43 
D SIM3m sPCNA 0.818±0.112 9.59±4.43 -13.11±2.40 -21.02 
E SIM12m sPCNA 0.658±0.112 12.97±6.80 -13.22±3.53 -21.99 
F SIM13m sPCNA 0.849±0.126 14.17±6.62 -8.01±1.68 -4.68 
G SIM23m sPCNA 1.115±0.186 20.21±14.22 -5.45±1.55 3.19 
H SIM123m sPCNA 0.804±0.098 13.85±5.93 -15.27±2.86 -28.99 
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mutants have subtle effects on the binding with sPCNA after data fitting (Figure 15 B-H). 
As listed in Table 4, the binding affinity of Elg1 SIM mutants was not dramatically 
decreased, compared to the Elg1 WT. Shown in Figure 15B-D, sPCNA was titrated into 
Elg1 single SIM mutants (SIM1m, SIM2m, and SIM3m), and the Kd only slightly 
decreased to 12.13±4.07 µM, 8.87±3.36 µM, and 9.59±4.43 µM, respectively. No dramatic 
changes were observed in all analyzed parameters. For these Elg1 mutants containing two 
SIM mutations, titrations with sPCNA had notably weaker titrating signals, especially 
SIM13m and SIM23m. Titration to the SIM23m that have mutations on SIM2 and SIM3 
had the weakest binding affinity (approximately 20 µM) among proteins tested in this study. 
The interactions for all Elg1 SIM mutants remain to be exothermic and have subtle 
alterations in apparent Kd. However, there was a significant change in ΔS for SIM13m and 
SIM23 when compared to the Elg1 WT. When sPCNA interacted with SIM13m, ΔS 
changed to -4.68 kcal/mol·K, and when sPCNA interacted with SIM23m, ΔS changed to 
3.19 kcal/mol·K, comparing to the Elg1 WT (ΔS= -20.57 kcal/mol·K). Furthermore, 
titration to SIM123m (contains mutations on three SIMs) had a similar apparent Kd 
(13.85±5.93 µM) with double SIM mutants and maintained similar ΔH (15.27±2.86 
kcal/mol) and ΔS (-28.99 kcal/mol·K) when compared to Elg1 WT, suggesting single SIM 
may not be enough to facilitate the interaction between Elg1 and sPCNA. 
3.1.6 Crystallization 
To determine the structural basis for the interactions between Elg1 and PCNA/sPCNA, we 
carried out crystallization of Elg1-PCNA complexes for three-dimensional structural 
information. Two methods were utilized to generate the complex of Elg1 with 
PCNA/sPCNA for crystallization.  
One method was to mix purified Elg1 proteins directly with PCNA/sPCNA at 1.2: 1 molar 
ratio and then concentrate the mixture to 10mg/ml for crystallization screening. A drop ratio 
of 1:1 was used in screening. One hit appeared in the condition (0.1 M Tris/Bicine pH 8.5, 
0.03 M MgCl2, 0.03 M CaCl2, 12.5% PEG 1000, 12.5% PEG 3350 and 12.5% MPD) from 
the Morpheus kit with the protein mixture of Mocr Elg1 21-84 and PCNA. The crystals 
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were cryoprotected and shot with X-ray, but they did not diffract. We also optimized around 
this condition, and a hit appeared in similar conditions (0.1 M Tris/Bicine pH 8.5, 0.03 M 
MgCl2, 0.03 M CaCl2 and 25% PEG 3350) (Figure 16A). Unfortunately, the crystals also 
did not diffract. The other method was to use synthesized peptides to form the complex 
with PCNA/sPCNA for screening. The sequence of the synthesized peptide is 
DSVIFLNHSVVKPIEAVSK, which contains the proposed PIP box in Parnas et al. [2] and 
original Elg1 residues 50-66. Unfortunately, the peptide was difficult to dissolve. We 
simply mixed PCNA with dialyzed peptide (still not dissolved, but the pH of the solution 
was adjusted to be the same as the buffer) and used the sample for screening. Several hits 
appeared (details are shown in Figure 16B-D), but these conditions need further 
optimization once we can confirm protein-complex crystals exist. 
3.2 Interactions between Elg1 and Smt3 
From the results above, the complexity of investigating the interaction with sPCNA 
hindered our progress. There are five putative motifs that are involved in the interactions 
with PCNA and SUMO, and little is known about how these motifs accommodate each 
other. Therefore, we altered the approach to investigate the interactions with Smt3, which 
could help us elucidate the roles of SIMs in the interaction with sPCNA. This may shed 
some light on the Elg1-sPCNA interaction and provides clues about Elg1-PCNA 
interaction. 
3.2.1 Cloning, expression, and purification of His-Smt3  
To investigate the role of different SIMs within the Elg1 N-terminus, we generated the 
constructs for expression and purification of His-Smt3, using the pMocr Smt3 Δ18K19R 
as the template. The plasmid pMocr Smt3 Δ18K19R codes the Smt3 mutant with 6 
histidines and Mocr tag at the N-terminus. The primers used for mutagenesis were designed 
following the protocol [59] to remove the Mocr tag and TEV cutting site, which directly 
linked the protein with the 6 histidines for the convenience of purification. The primers  
47 
 
 
 
  
Figure 16: Crystal hits observed from kits. 
A) Crystals observed in the condition (0.1 M Tris/Bicine pH 8.5, 0.03 M MgCl2, 0.03 M 
CaCl2, and 25% w/v PEG 3350), with protein mixture of Mocr Elg1 21-84 and PCNA; B) 
Crystals observed in the condition (0.1 M Tris pH 8.0, 0.2 M Magnesium chloride 
hexahydrate, and 20% w/v PEG 6000) with mixture of PCNA and peptide; C) Crystals 
observed in the condition (0.1 M Sodium acetate pH 5.0, 0.2 M Magnesium chloride 
hexahydrate, and 20% w/v PEG 6000), with mixture of PCNA and peptide; D) Crystals 
observed in the condition (0.1 M MMT pH 5.0 and 25% w/v PEG 1500), with mixture of 
sPCNA and peptide. 
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were synthesized by UWO Oligo Factory (Appendix A). 
After we achieved the correct construct, it was expressed and induced as described in 
Materials and Methods. The expressed protein was purified via nickel affinity 
chromatography and anion exchange chromatography. As shown in Figure 17A, His-Smt3 
was eluted with His Buffer B. The eluted protein was diluted to approximately 100 mM 
NaCl for loading onto the Q HP columns (GE Healthcare). A gradient of Anion Buffer B 
(10% to 30% in 10 column volumes) was applied to purify His-Smt3. The purity of His-
smt3 was checked with SDS-PAGE, and fractions that contain sufficiently pure protein 
(Figure 17B) were pooled and concentrated to over 10 mg/ml. Flash frozen method with 
liquid nitrogen was used to store the protein for future assays. Normally, approximately 15 
mg protein would be obtained from one-liter of culture. 
3.2.2 GST pull-down assay 
From the GST pull-down assay performed before, no interaction between Elg1 and Smt3 
was detected by this method. For the sake of accuracy, we performed this assay again with 
a higher protein concentration and a higher molar ratio of concentration via the same 
method. In order to test the interaction of different SIMs with Smt3, we deliberately chose 
four Elg1 fragments: Elg1N (contains all three SIMs), Elg1L1 (contains SIM1 and SIM2), 
Elg1L2 (contains SIM1), and Elg1L3+ (contains no SIMs). Also, GST with Smt3 and GST-
p21 with hPCNA were used as the negative control and positive control, respectively. 
Although we overloaded the SDS-PAGE gel, no obvious Smt3 bands were detected (Figure 
18). This result suggests that the interaction between Elg1 and Smt3 is not suitable to be 
detected via GST pull-down. 
3.2.3 ITC 
Since the GST pull-down assay was not sensitive enough to detect the interaction with 
Smt3, we used ITC to verify the interaction between Elg1 N-terminus and Smt3, due to 
ITC’s ability to detect a wide range of binding affinity, from mM to nM. Also, for the 
benefit 
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Figure 17: Purification of His-Smt3. 
A) Nickel affinity chromatography of His-Smt3 purification. The experiments were 
performed with nickel columns. Cell lysis, soluble protein, loaded sample, wash, and 
elution are indicated. 
B) Anion exchange chromatography of His-Smt3 purification. This procedure was 
performed on Q HP columns. The loaded sample, flow through (FT), and elution (with 
Anion Buffer B) are indicated.
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Figure 18: GST pull-down assay with Elg1 N-terminal fragments and Smt3. 
The negative control experiment was prepared with GST as the bait. The positive control 
experiment was prepared with GST-p21 as the bait and hPCNA as the prey. This assay used 
a higher molar concentration ratio and higher protein concentration of GST-fused Elg1 
fragments.  No positive detection of Smt3 were shown with these Elg1 constructs used.
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Figure 19: ITC titration between His-Smt3 and Elg1, or Elg1 SIM single mutants. 
All titrations were performed at 25°C with a stirring speed of 250 rpm. The control 
experiments were shown in green, and the protein to protein titration experiments were 
shown in red. A) 0.72 mM Elg1 WT titrated to 0.1 mM His-Smt3; B) 0.56 mM SIM1m 
titrated to 0.1 mM His-Smt3; C) 0.78 mM SIM2m titrated to 0.1 mM His-Smt3; D) 0.68 
mM SIM3m titrated to 0.1 mM His-Smt3. 
 
 
 
 
Table 5: Summary of the ITC titrations between His-Smt3 and Elg1 
  Protein in Cell Protein in Syringe Multiply by N Kd(µM) ΔH(kcal/mol) ΔS(kcal/mol·K) 
A His-Smt3 Elg1 WT 3 1.096±0.417 80.5±34.3 -2.66±1.58 9.82 
B His-Smt3 SIM1m 2 0.523±0.266 131.8±25.4 -8.11±6.03 -9.45 
C His-Smt3 SIM2m 2 0.686±0.185 77.8±16.4 -3.52±1.26 7.00 
D His-Smt3 SIM3m 2 0.991±0.315 73.8±29.1 -2.38±1.19 10.92 
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of purification, we had prepared another construct, His-Smt3 Δ18K19R, which expressed 
protein with 6 extra histidines at the N-terminus.  
For the titration of 0.72 mM Elg1 WT to 0.1 mM His-Smt3, we subtracted the signal from 
the titration to buffer and used Nanoanalyze to fit the independent binding model. Assuming 
all three SIMs bind to Elg1 identically, we manually multiplied the concentration of Elg1 
WT by 3 when we analyzed the data. Shown in Table 5, the apparent binding affinity for 
Smt3 is 80.5±34.3 µM, suggesting Smt3 binds to SIM in a weak manner. It gives an N value 
of 1.096±0.417, which corroborated our assumption that one Elg1 N-terminal fragment 
binds three Smt3. We assume that the mutation on SIMs would abolish their binding ability 
to Smt3. Therefore, with these Elg1 SIM mutants, we multiplied the concentration of Elg1 
mutants by the number of the rest binding sites, 2 in this case. It seems that mutation on 
SIM1 has the largest impaired effects on the apparent Kd, which decreased 1.6-fold to 
131.8±25.4 µM. This result suggests that SIM1 may be the dominant SIM for the 
interaction with Smt3. In addition, mutations on SIM2 and SIM3 have similar apparent 
binding affinity as Elg1 WT. The apparent Kd maintained to 77.8±16.4 µM for SIM2m and 
73.8±29.1 µM for SIM3m, suggesting SIM2 and SIM3 have the ability to bind Smt3, but 
not as tight as SIM1. Also, they have some differences in the N value. The mutations on 
SIM3 did not affect the N value compared to Elg1 WT, but mutations on SIM2 have a 
relatively significant alteration in the N value, which decreased to 0.686±0.185. The change 
on the N values is likely caused by the possibility that alanine mutations on the SIMs did 
not fully abolish their binding abilities to Smt3. Subsequently, this interfered the analysis 
since we assume the otherwise. These results further indicate that all three SIMs contribute 
to the interaction with Smt3. 
3.2.4 NMR 
Although no interaction was detected in our GST pull-down assay, alternative research has 
revealed the binding between Smt3 and Elg1 via the yeast two-hybrid method [2]. Our ITC 
experiments also confirmed the existence of the interaction between the Elg1 N-terminus 
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and Smt3. However, the stoichiometry from ITC needs to be further investigated. 
Additionally, NMR experiments with titration can be employed to further validate protein 
interactions and provide clues about the binding model.  
NMR was first used to calculate the apparent binding affinity. As described in the Materials 
and Methods section, the proteins used for this experiment were exchanged into the NMR 
buffer. The concentration of the protein samples was validated by amino acid analysis. 
Using 61 µM Smt3 as standard, we used NMR to measure the surface residues’ chemical 
shifts while mixed with 42 µM, 84 µM, 168 µM, and 336 µM Elg1 WT. The signals were 
processed by NMRPipe and NMRviewJ. Since the Smt3 solution structure was determined 
[64], we were able to assign most of our residues based on the relative positions of the 
signal peaks. The 2D spectrum of Smt3 is shown in Figure 20, and those residues that 
exhibit large chemical shifts are shown in Figure 21. The residues showing relatively large 
shifts were used to calculate the apparent binding affinity (Table 6). We set the 
stoichiometry to 1:3 (Elg1: Smt3), which assumes one Elg1 molecule binds to three Smt3 
with equal contributions of three SIMs, and the apparent binding affinity would be 
determined to approximately 150 µM (Figure 22). This binding affinity suggested that Smt3 
binds to Elg1 weakly. The fitting curves in Figure 22 all have an R2 of over 0.97. R2 is 
known as the coefficient of determination, which is always between 0 and 1. In general, the 
higher the R2, the better the model fits your data.  
Furthermore, the chemical shifts data from NMR could be used to map the surface of Smt3 
that is involved in the interaction between Elg1 and Smt3. Using the equation in the 
Materials and Methods section, we had minimized the artificial effects from the range 
difference between 1H and 15N. We applied these calculations to all assigned residues and 
discovered several residues on Smt3 that were shifted significantly with Elg1 binding. 
Shown in Figure 23, most residues that have large chemical shifts were located on the β 
sheet-1, β sheet-2, and α helix in the N-terminus of Smt3. Two Smt3 structures were utilized 
to map Smt3’s interacting face. One is the structure of Smt3 binding to Srs2’s SIM (PDB 
ID: 3V62) [26], those residues that were shifted with Elg1 binding (based on our NMR 
 
 
 
 
  
Figure 20: 2D 1H-15N spectrum of Smt3 Δ18K19R with assignments. 
This spectrum of Smt3 is obtained at 25°C and pH 7.5. Backbone amide resonances are labelled with the one-letter code and residue number 
in this 2D spectrum. (The spectrum also shows several additional peaks from asparagine, glutamine, and arginine side chain resonances, which 
are the peaks connected with solid lines.)
5
5 
 
 
 
 
 
Figure 21: 2D 1H-15N spectrum of Smt3 Δ18K19R, free and in complex with various concentrations of Elg1 WT. 
The spectrum of free Smt3 is shown in black, and the spectrums of the mixture with various ratios of concentration between Elg1 and Smt3 
are indicated with different colors. This spectrum of Smt3 is obtained at 25°C and pH 7.5. Residues with relatively large chemical shifts 
(larger than average) are marked with the one-letter code and residue number. (The spectrum also shows several additional peaks from 
asparagine, glutamine, and arginine side chain resonances, which are the peaks connected with solid lines.) 
5
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Figure 22: The fitting curves of chemical shifts used to calculate binding affinity. 
The curves represent the fit of the equation to describe the situation that all three SIMs 
bind to Smt3 identically and Kd was calculated in the same equations.  
A) Based on the chemical shifts of 1H, the curves correspond to Kd=142.3±6.1 µM.  
B) Based on the chemical shifts of 15N, the curves correspond to Kd=153.4±7.8 µM. 
  
 
Table 6: Summary of chemical shifts for apparent Kd in NMR 
 
 
 
 
Elg1 concentration 
(µM) 
Smt3 concentration 
(µM) 
Residues' chemical shifts in 1H (ppm) 
T43 D68 I72 T77 
42 61 0.020 0.012 0.014 0.007 
84 61 0.031 0.020 0.023 0.012 
168 61 0.044 0.027 0.033 0.016 
336 61 0.052 0.033 0.037 0.019 
  
    
Elg1 concentration 
(µM) 
Smt3 concentration 
(µM) 
Residues' chemical shifts in 15N (ppm) 
T43 L48 I72 T77 
42 61 0.20 0.07 0.29 0.13 
84 61 0.34 0.14 0.46 0.21 
168 61 0.47 0.16 0.63 0.29 
336 61 0.57 0.19 0.78 0.34 
5
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Figure 23: Chemical-shift perturbations of assigned residues in Smt3 Δ18K19R. 
The chemical-shift perturbations are calculated with the equation described above and are plotted with their residue numbers. The secondary 
structure of Smt3 is also indicated in the bar diagram below. It shows most residues that have large chemical shifts are in the β sheet-1, β sheet-
2, and α helix. The orange horizontal line represents the average overall chemical shifts (0.069 ppm), and the blue horizontal line represents 
the overall chemical shifts (0.143 ppm) that equal to the average overall chemical shifts plus one standard deviation. 
5
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Figure 24: Elg1 binding surface mapped on the Smt3. 
The Elg1 binding surface was mapped utilizing the Smt3 structure from PDB ID: 3V62 
(panel A and B) and 2EKE (panel C and D). Smt3 structures are presented in gray. Residues 
with overall chemical shifts above the average based on our NMR data were mapped the 
Elg1-Smt3 interacting surface in blue. 
A) The structure of Smt3 from 3V62. The Elg1-Smt3 interacting surface is mapped in blue. 
B) The structure of Smt3 binding to Srs2 SIM. The surface of Srs2 SIM is presented in red. 
It shows that Elg1 binds to Smt3 in the same side as Srs2 binds to Smt3. 
C) The structure of Smt3 from 2EKE. The Elg1-Smt3 interacting surface is mapped in blue. 
D) The structure of Smt3 binding to yUbc9. The structure of yUbc9 is presented in red. It 
shows that Elg1 binds to Smt3 in the opposite side as yUbc9 binds to Smt3. 
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data) were mapped in blue (Figure 24A). Interestingly, it resembles the surface where Srs2 
SIM binds (Figure 24B). Another structure we used is the structure of Smt3 binding to 
yUbc9 (PDB ID: 2EKE) [65]. Those shifted residues were also mapped in that structure 
(Figure 24C). We found out that the interface of Smt3 binding to yUbc9 is on the opposite 
face of where we mapped (Figure 24D). It is likely that Smt3 binds to Elg1 in a similar 
manner as Srs2, instead of yUbc9. 
4 Discussion 
4.1 Elg1’s interaction with PCNA 
4.1.1 Two PIP boxes participate in the interaction with PCNA  
Despite the lack of a canonical PIP box sequence, Elg1 has been shown to bind to PCNA 
in the yeast-2-hybrid assay. Elg1 also preferentially binds to sPCNA [2]. In this work, two 
biochemical methods, GST pull-down assay and ITC, have been employed to assess the 
interaction between Elg1 and PCNA. In our hypothesis, we speculated that two PIP boxes 
are involved in the interaction with PCNA. The first one is very similar to the PIP box 
proposed by Parnas et al. [2], and the second one is based on our lab’s previous 
investigations.  
Parnas et al.’s analysis proposed the PIP box of Elg1 located between amino acids 43 and 
67 using different Elg1 N-terminal fragments in yeast-2-hybrid assays [2]. Similarly, our 
results in the pull-down assays confirmed Elg1’s binding ability with PCNA. In our GST 
pull-down assays, only Elg1L3 (46-84) and Elg1L3+ (33-84), the fragments containing two 
PIP boxes and excluding all three SIMs, demonstrate PCNA binding. Although the shorter 
fragment Elg1L5 (64-84) fails to show the interaction with PCNA, it does not exclude the 
weak binding of PIP2 and the possibility that two PIP boxes work together to facilitate the 
interaction with PCNA. In addition, we also used ITC for further investigations, where we 
titrated PCNA to Elg1L3+. But the ITC result fails to provide solid evidence for 
characterizing this interaction. There are two possibilities for this failure on ITC. One is 
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that the titration of the Elg1 fragment to PCNA is prone to aggregations. It would be similar 
to the case of titrating Elg1 fragment to sPCNA. Second is that the concentration we used 
may cause the Elg1 fragment to not fold properly. Although Elg1 fragment was expressed 
together with GST tag for better solubility, there remains the possibility that Elg1 fragment 
becomes less functional to the interaction with PCNA due to the improper folding at high 
concentration for titration. Collectively, our GST pull-down assays have confirmed Elg1 
N-terminus’s interaction with PCNA in vitro, and two PIP boxes participate in this 
interaction. 
4.1.2 SIM1 and/or SIM2 may inhibit the interaction with PCNA 
Elg1 contains three SIMs that were shown to interact with SUMO in yeast-2-hybrid assays 
[2]. Armstrong et al. [26] have demonstrated the PIP box’s interaction with PCNA and 
SIM’s interaction with SUMO are independent of each other in Srs2. But our GST pull-
down assays suggest that the SIM(s) of Elg1 may interfere with the interaction with PCNA. 
With sPCNA as prey, multiple fragments, including Elg1L3 (46-84), Elg1N, and Elg1L1 
(21-102), were detected to show binding with sPCNA. Elg1N contains all three SIMs, and 
Elg1L1 only contains SIM1 and SIM2, while Elg1L3 contains no SIMs. However, Elg1N 
and Elg1L1 did not show interactions with PCNA, while Elg1L3 showed binding with 
PCNA. We suspect that SIM1 and/or SIM2 inhibit the interaction with PCNA. When PCNA 
was SUMOylated, SIM1 and/or SIM2 bind to SUMO that is conjugated to PCNA and 
possibly changed the conformation of the Elg1 N-terminus, subsequently promoting the 
PIP box’s interaction with PCNA. 
In order to exclude the possible inhibitory effects of SIMs and test if the PIP box1 can bind 
to PCNA alone, we attempted to use synthesized peptide that contains original residues 50-
66 of Elg1 for further investigations. Several past studies have determined the structure of 
the PCNA-peptide complex [26, 43]. We hoped that a higher concentration of peptides 
could allow for a more accurate analysis in the ITC and form the complex with PCNA for 
screening. Despite the prediction that the peptide would be soluble, this was not the case, 
especially for the aqueous buffers. We directly mixed the PCNA and the pH-adjusted 
63 
 
 
 
peptide solution, and the mixture was directly used to screen for crystals. Although several 
hits were observed, those crystals needed to be verified as protein-peptide complexes, 
instead of PCNA alone, and those conditions needed further optimization. Without a clear 
structure of the PCNA complex with the Elg1 PIP box, it is difficult to identify the PIP box 
residues that formed the hydrophobic plug that interacts with the IDCL of PCNA. Though 
our attempt to use the synthesized peptide did not work, other approaches, such as in silico 
alanine scanning, can be employed to derive more information. 
4.2 Elg1’s interaction with sPCNA 
4.2.1 Elg1 N-terminus is confirmed to bind sPCNA with µM affinity 
According to previous research [1-2], Elg1 would preferentially bind to sPCNA and this 
binding is mediated by the SIMs in the N-terminal. Our GST pull-down assays confirmed 
the binding with sPCNA, via using Elg1 46-84, Elg1 21-150, and Elg1 21-102 as bait 
(Figure 13). In addition, we determined the apparent Kd of interaction between the Elg1 N-
terminus and sPCNA through ITC. Elg1 WT binds to sPCNA with an apparent Kd of 
8.23±3.31 µM, and an N value of 1.122±0.073 (Table 4). 
However, this binding affinity is much weaker than expected. Armstrong et al. [26] have 
established that the Srs2 C-terminal can bind to sPCNA with a Kd of approximately 25 nM 
via fluorescence polarization assays, which is a much tighter binding than what we 
observed. The reason for the large difference is probably because the PIP box of Elg1 binds 
to PCNA in a much weaker manner than the Srs2 C-terminus. We were able to determine 
that the Elg1 N-terminal binds to sPCNA in µM affinity with ITC, but further 
characterizations are required to uncover how the two protein-protein interactions, namely 
SIM binding to SUMO and the PIP box binding to PCNA, accommodated each other. 
4.2.2 SIMs mutations have subtle effects on the interaction with sPCNA 
Previous research has shown that all three SIMs are capable of interacting with Smt3 via 
yeast-2-hybrid assays [2]. From our GST pull-down results, SIM1 and SIM2 are needed for 
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the interaction with sPCNA. Deletion of SIM3 seems to have minor effects on the 
interaction with sPCNA. Moreover, ITC experiments with various SIMs mutants were 
conducted to shed some light on the mechanism of the binding with sPCNA. The results 
show that the interaction with sPCNA is not affected dramatically by mutations on SIMs. 
The apparent Kd decreased at most 2-fold with mutant Elg1 SIM23m. These results indicate 
that the interactions between SIMs and SUMO slightly contribute to Elg1’s interaction with 
sPCNA. Since the mutations on all three SIMs only hinder the interaction with sPCNA to 
a small extent, we suspect that SIMs probably play a minor role in anchoring to PCNA. 
Only the mutation in the SIM1 exhibit a 1.5-fold decrease in the apparent binding affinity. 
However, with mutations on the double SIMs, their ΔS have significant differences, despite 
still having a similar level of apparent Kd. It implied that three SIMs in the Elg1 N-terminal 
may bind to sPCNA with different binding mechanisms. To be noticed, most ITC titrations 
have an N value of close to 1, except for the SIM12m. It is probably because this titration 
between sPCNA and SIM12m were conducted at last, which the protein may not be as 
effective as the fresh protein. 
To discover the role of the SIMs in the interaction with sPCNA, various combinations of 
mutations on SIMs were generated and tested. Unexpectedly, SIMs mutations have subtle 
effects on the interaction with sPCNA.  
4.3 Elg1’s interactions with Smt3 
4.3.1 Elg1 N-terminus is confirmed to bind Smt3 weakly 
Parnas et al. have shown that the Elg1 N-terminus can bind Smt3 in yeast 2-hybrid 
experiments, and all three SIMs can also bind Smt3 [2]. To better characterize the 
interaction with Smt3, GST pull-down assays and ITC experiments were employed. 
However, our GST pull-down assays did not show a detectable interaction between the 
Elg1 N-terminus and Smt3. 
Our ITC experiments determined that the Elg1 N-terminal binds to Smt3 with an apparent 
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Kd of approximately 80 μM (Table 5), while Elg1 binds to sPCNA with an apparent Kd of 
approximately 8 μM (Table 4). Additionally, our NMR experiments further confirmed that 
Elg1 binds to Smt3 weakly. As shown in Figure 21, some residues of Smt3 have chemical 
shift changes upon Elg1 binding. Those residues with large chemical shifts were used to 
calculate the Kd. With the assumption of an n value as 3.0 (n represents the number of 
binding sites on Elg1), the Kd is calculated to be approximately 150 µM (Figure 22). The 
reason why the Kd that measured via ITC and NMR are different is that ITC has large 
deviation when determining the Kd of low-affinity interaction. For low-affinity interaction, 
the inflections of ITC titrations are not well defined to accurately determine Kd. To be noted, 
the fitting strategy we used is not accurate, since all three SIMs would not be identical. 
Characterizing the interaction between the Smt3 and only one SIM would be the practical 
strategy for further investigation. The NMR experiments with peptides that only contain 
one SIM titrating to Elg1 would be suitable to better characterize this binding model.  
4.3.2 All three SIMs contribute to the interaction with Smt3 
In our ITC experiments, we were able to determine the apparent Kd of binding Smt3 is 
80.5±34.3 µM (Table 5). This also gives an N value of 1.096±0.417, which support our 
assumption that one Elg1 binds three Smt3.  
In order to understand the role of SIMs in the interaction with Smt3, various constructs that 
contain SIMs mutations were generated and the expressed proteins were utilized in the ITC. 
Also, as shown in Table 6, mutations on single SIMs dramatically affect the apparent Kd. 
Mutations on SIM1 have the largest impaired effects on the apparent Kd, which decreased 
1.6-fold to approximately 132 µM. This result suggests that SIM1 may be the dominant 
SIM for the interaction with Smt3, likely the same case for interacting with sPCNA. 
Mutations on SIM2 and SIM3 maintain the similar apparent binding affinity, compared to 
the Elg1 WT, suggesting SIM2 and SIM3 bind to Smt3 in a manner weaker than SIM1. 
Collectively, all three SIMs contribute to the interaction with Smt3, and SIM1 probably is 
the major one that is responsible for the interaction.  
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4.3.3 Elg1’s interaction with Smt3 is likely to resemble Srs2 interactions 
Our NMR experiments not only provide us a clue about the apparent Kd, but also shed more 
light on the mechanism of how the SIM(s) of Elg1 bind(s) to Smt3. Based on the assignment 
of Smt3, the chemical shifts of most residues on the Elg1 N-terminus were calculated. 
Shown in Figure 23, most residues that have large chemical shifts were located on β sheet-
1, β sheet-2, and the α helix in the Smt3 N-terminus. Based on the chemical shifts, we 
mapped the Elg1 binding surface using two known Smt3 structures, Srs2 bound by C-
terminus and Smt3 in complex with yUbc9. Interestingly, the mapped surface resembles 
the one from Srs2’s C-terminus (Figure 24B). In addition, it is unlikely that all three SIMs 
bind to one single Smt3. It is possible that all three SIMs play different roles in the 
interaction with Smt3 or sPCNA. Despite more questions having arisen during our 
investigations, determining the structure of Elg1 binding to Smt3 could provide insight into 
the SIM-SUMO interaction models. Approaches, such as NMR with Elg1 SIM mutants, 
can be employed to help determine the structure of Elg1’s SIM binding to Smt3. 
4.4 Proposed model for interactions with PCNA/sPCNA 
Combining our results, we propose the following model for Elg1 and PCNA/sPCNA 
interaction (the schematic model is presented in Figure 25): 
To maintain normal replication processes, Elg1 exhibits a weaker ability to bind PCNA than 
other PCNA partners, such as polymerases. SIM(s) may partially cover the PIP box on the 
Elg1 N-terminus and inhibit the interaction between Elg1 and PCNA. Upon DNA damage 
and/or other cofactors, PCNA undergoes SUMOylation to promote its binding with Elg1, 
which subsequently promoting Elg1-RLC’s unloading function. Therefore, PCNA would 
not stay on the replication fork, and the replication process can proceed. With 
SUMOylation, SUMO is conjugated to PCNA, mostly at K164. The SIM(s) in the Elg1 N-
terminal would bind to the Smt3, anchoring Elg1 and stabilizing Smt3’s orientation, and 
the SIM(s) cease(s) to interfere with the interaction between the PIP box and PCNA, 
subsequently promoting the PCNA unloading activity. 
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4.5 Future directions 
In this study, we have made progress to elucidate the interaction of the Elg1 N-terminus 
with PCNA, sPCNA, and Smt3. For the interaction with PCNA, we have shown that two 
PIP boxes participate in the PCNA binding. The binding is significantly weaker than that 
of most PIP boxes and PCNA interactions, and SIM(s) may play an inhibitory role in this 
interaction. Based on the results, we propose the model for Elg1’s interactions with 
PCNA/sPCNA, which provides us with a better understanding about the role of Elg1 as a 
general unloader of PCNA. Although we currently cannot pinpoint the exact residues of the 
PIP box and determine the structural basis of Elg1-PCNA interaction, we have a clue on 
this interaction, which is probably from the inhibitory effect from SIM(s). Better construct 
design is required to investigate the interaction with PCNA, and experiments, such as 
alanine scanning and NMR, can be employed for further characterizations. 
Upon DNA damage, PCNA would be SUMOylated. The feature that Elg1 preferentially 
binds to sPCNA implies a role of Elg1 in DNA damage. We determined that the interaction 
has an apparent Kd of approximately 8 µM. Mutations on SIMs have subtle effects on the 
apparent Kd. In addition, we have shown that all three SIMs in the Elg1 N-terminus 
contribute to the binding with Smt3. However, since one Smt3 can only accommodate one 
SIM, all three SIMs may contribute to different roles. These results indicate that SIMs play 
different roles in the interaction with sPCNA. Characterizing their different roles would 
help us understand how Elg1 regulates the PCNA unloading and how SUMOylation affects 
PCNA unloading. NMR experiments with peptide that contains only one SIM would better 
characterize the binding model between Elg1 and Smt3, and some in vivo work about the 
SIMs would be shed some light on Elg1’s functions.  
Although several aspects of this study require further investigations, progress has been 
made to understand the interactions between Elg1 and PCNA/sPCNA. Further 
investigations on these interactions will provide us with more insight into the PCNA 
unloading process and better understanding about the roles of Elg1 in DNA replication and 
damage response.
 
 
 
 
 
 
Figure 25: Proposed model of the interactions between Elg1 and PCNA/sPCNA.  
Based on our results, we proposed a model to describe the interactions between Elg1 and PCNA/sPCNA. PCNA is shown as the blue ring. 
The motifs in the Elg1 N-terminus are colored as yellow for SIMs and gray for the PIP box. The S represents the SUMO. 
A) During normal replication, the interaction between the PIP box of Elg1 and PCNA is inhibited by adjacent SIMs. The PIP box of the Elg1 
binds to PCNA, which is represented by the black dashed line. 
B) Upon DNA damage, PCNA would undergo SUMOylation and SUMO would be conjugated to PCNA at K164.  
C) After PCNA is SUMOylated, SIM1 or SIM2 would bind to the SUMO, alleviating the inhibitory effects on the interaction between the 
PIP box and PCNA. The PIP box of Elg1 can bind to PCNA in a much stronger manner. 
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6 Appendices 
Appendix A: Table of primers that were used to generate new constructs. 
For Mutations Sequence 
I26A, I28A (SIM1) 
5’- gccaccgcagatgacgaaaatgatactgaatcaggcac -3’ 
5’- gtcatctgcggtggctgtagagcatcttgccaggattg -3’ 
L92A, I93A, V94A, I95A 
(SIM2) 
5’- gcagcggcagccagtgataagagtcccaaaagtgagactaattg -3’ 
5’- actggctgccgctgcatcatcatcgtcgtcatcgc -3’ 
I118A, I120A, I121A 
(SIM3) 
5’- gcgtctgcagcctccacatcgagaatcaaatcatcgcttc -3’ 
5’- ggaggctgcagacgcatcatcttcatgctcctgcg -3’ 
6 histidines were directly 
linked to Smt3 
5’- catcatcattcccgccctgagactcacatcaatttaaaggtgtcc -3’ 
5’- agggcgggaatgatgatgatgatggtgcatatgtatatctccttc -3’ 
 
 
 
Appendix B: SUMOylation tested at different time points. 
The reaction took place in a 1 ml system, and 10 µl of sample were taken at each time point 
for SDS-PAGE analysis. The lane labeled “noATP” represent the reaction sample that has 
not added ATP to initiate the reaction. The following lanes represent the situation of the 
reaction samples after various time points. The amount of PCNA and Smt3 gradually 
decreased, while more sPCNA was produced.  The positions of double-SUMOylated 
PCNA, sPCNA, PCNA, and Smt3 are indicated on the right. 
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Appendix C: ITC titration of Elg1 and PCNA. 
Protein 830 µM PCNA were titrated into 79 µM GST Elg1L3+ (33-84) at 25°C with a 
stirring speed of 250 rpm. This titration presented as a situation of no saturation after full 
injection, which makes the analysis inaccurate. This titration was analyzed by the program 
with an apparent Kd of over 424 µM and N of 0.775±1.206.  
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